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is as strange a maze as e*er men trod. 
And there is in this business more than nature 
Was ever conduct of*
William Shakespeare - The Tempest, Act V. Scene 1
ABSTRACT
Induction of lymphocyte motility is an essential early step in extravasation of lymphocytes 
into inflammatory sites and also into lymphoid tissues in the process of lymphocyte 
recirculation. Lymphocyte motihty requires a change from a spherical morphology to a 
constantly changing irregular shape. In this study, a variety of agents have been 
investigated for induction of this shape changing morphology in freshly isolated human 
peripheral blood T-lymphocytes (PBTLs) and a non-motile variant of the MOLT-4 human 
lymphoid cell line. The MOLT-4 cells proved to be non-responsive to most of the agents 
tested, however, 5 agents were found to cause significant polarisation in PBTLs. IL-2, IL- 
15, fetal calf serum (PCS) and nocadazole induce shape change in 20-40% of PBTLs. 
However, the most potent inducer of shape change found were the PKC inhibitors of the 
bisindolylmaleimide (Bis) type, which show effects on over 60% of PBTLs, as reported 
recently^^^*\ Do these diverse inducers of shape changing in PBTLs act by a common signal 
transduction pathway? With IL-2, IL-15, PCS, nocadazole and Bis., no common changes in 
intracellular calcium flux, intracellular pH, inositol triphosphate levels, renaturable kinase 
activity and tyrosine phosphorylation have been found. So if a final common signal 
transduction pathway exists, it must involve other second messenger systems.
However, a number of pharmacological agents were found to prevent the induction of 
shape change in PBTLs, indicating that they could be targeting a common second 
messenger element involved in motility signal transduction. Comparisons of their chemical 
structures revealed no common structural motifs that would explain their common effects 
on lymphocyte motility
ii
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i1. Introduction
I
The circulatory and migratory properties of white blood cells have evolved to allow 
efficient surveillance of tissues for infectious pathogens and rapid accumulation at sites 
of injury and infection. Lymphocytes exhibit complex migration pathways in the body. 
Resting blood lymphocytes which are predominantly non-motile recirculate selectively 
through specific lymphoid tissues; activated lymphocytes migrate selectively into 
inflammatory sites. Lymphocyte adhesion and extravasation appear to constitute a 
multistep phenomena (figure 1.1), in which the initial (stage 1), relatively low-affinty 
binding event ("rolling") is mediated by the selectin family of adhesion molecules^^'^\ 
Chemotactically activated lymphocytes, (stage 2) then induce a higher avidity binding, 
(stage 3) that is mediated by the lymphocyte integrins and their cognate endothelial 
ligands, the immunoglobulin superfamily glycoproteins including the intercellular 
adhesion molecules (ICAMs) and vascular cell adhesion molecule-1 (VCAM-1)^^\
Adherent cells then transmigrate, (stage 4) through the endothelium. However, adhesion 
alone cannot be sufficient to bring about the transendothelial migration of lymphocytes, a 
process which entails active movement of cells and shape change.
The specificity of lymphocyte migration is now beginning to be understood at the level 
of endothelial adhesion but the details of what causes the lymphocyte to subsequently 
become motile and traverse the endothelium are still shrouded in mystery. It is this latter 
crucial step in the multi-step procedure of lymphocyte extravasation that I shall 
especially concentrate on and the evidence so far accumulated on the signal transduction 
processes involved that link the extracellular signals originating at the plasma membrane
Figure 1.1 : The four step model of lymphocyte transendothelial
migration.
The four step model of Ivmphocvte transendothelial migration.
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to the organisation of the cytoskeletal network which is involved in influencing cell shape 
and thus motility.
1.1; Background
In 1875 Ranvier was the first to suggest that lymphoid cells were motile^*®. This 
concept received enthusiastic support by others, however, objections were raised by 
several research workers, including P. Ehrlich, according to whom the lymphocyte had 
too little protoplasm to push the voluminous nucleus along^^ '^^^^\
In 1921 Lewis and Webster and in 1923 Sabin clearly demonstrated lymphocyte motility 
with intermittent stops and starts and the presence of a trailing cytoplasmic tail^ ^^ ’^^ ^°\ 
The classic description of the morphology of moving lymphocytes was presented by 
Lewis in 1931^^\ Lewis described the motile lymphocyte as a polarised asymmetric cell 
in a configuration resembling that of a hand mirror with a thin advancing pseudopod, a 
rounded area enclosing the anteriorly placed nucleus and a trailing tail of cytoplasm. 
McFarland extended the studies of the cytoplasmic tail of the amoeboid lymphocyte and 
termed this extension of cytoplasm, the uropod^^^'^^\ The uropod was demonstrated to 
be a part of the cell not only associated with cell movement but with a variety of 
lymphocyte interactions with the environment, including other cells. The uropod is 
covered with microvilli and contains the golgi apparatus, mitochondria, rough 
endoplasmic reticulum, centrioles, microfilaments and microtubules^^ '^^’^ ^^  ^ In contrast to 
the uropod, the advancing edge of the lymphocyte, which was described by the early 
investigators to be the most substrate adherent area of the cell, is generally devoid of 
major cytoplasmic organelles.
The regulation of lymphocyte motility involves multiple control mechanisms, some of 
which are only partly understood at present. Within the organism, lymphocytes must 
move actively to specific sites in lymphoid and non-lymphoid tissues. This most likely 
requires that lymphocyte motility is switched on and off and guided in a precise way 
For a relatively long time, leukocyte motility and translocation, particularly chemo- and 
haptotaxis, were studied preferentially using granulocytes and monocytes^^’^ ^ \^ This 
was despite the obvious fact that motility must be important for the function of the 
lymphocytes, both as recirculating cells and in immune responses. Thus, an abundance 
of information was accrued on granulocyte migration and chemotaxis, whereas relatively 
little was known about the corresponding events in lymphocytes.
A major reason why lymphocyte motility, migration, chemo- and haptotaxis did not 
receive major attention until “later” was poor lymphocyte in vitro migration assays and 
the non adhesiveness of lymphoid cells for noncellular substrates. Thus, lymphocytes 
maintain their spherical suspension shape and show poor motile behaviour under 
conditions in which fibroblasts and macrophages adhere and spread their cytoplasm over 
substrates. Lymphocytes can exhibit motile forms in suspension without anchorage to 
cellular and non cellular substrates. Lymphocyte motility is often determined in vitro 
when the cells are nonadherent using the number of polarised cells as a measure of 
motility^^^^\ However, it must be emphasised that the extension of pseudopods and 
migration of cells are separable because pseudopod formation is not always followed by 
migiation®^ '^^^^ .^
In conclusion, T lymphocyte motility depends on the capacity of the cells to form active 
cell edges, the binding capacity of lymphocyte adhesion receptors, the availability of 
adhesion ligands, and the capacity of the cells to de-adhere and perform repeated cycles 
of motile events leading to translocation.
1.2: Lymphocyte - endothelial recognition.
To enter the various lymphoid tissues involved in recirculation, blood lymphocytes have 
to cross the endothelial vascular lining (except in the spleen, where small penicillar 
arterioles end in the parenchyma, thus allowing unhampered access of blood leukocytes). 
The process of lymphocyte extravasation in lymphoid tissues occurs at specialised post­
capillary vascular sites called high-endothelial venules (HEVs)^^\ Our understanding of 
the mechanisms of this selectivity has been advanced by the discovery that naive and 
memory lymphocytes prefer different recirculation pathw ays.W hen naive lymphocytes 
encounter antigen, those lymphocytes with receptors specific for the antigen are 
stimulated to expand clonally and are converted to memory lymphocytes that have 
altered expression of adhesion receptors and circulatory p a tte rn s .F o r peripheral tissues 
and lymph nodes, memory lymphocytes emigrate preferentially through tissue 
endothelium, whereas naive lymphocytes enter the lymph node through HEVs.
Recent research has started to identify the molecules involved in adhesion of 
lymphocytes to HEVs and endothelium (figure 1.2). L-selectin on the surface of the 
lymphocytes has been found to have various ligands, depending on the site in the 
body^^°^ and recognises a carbohydrate epitope on several biochemically distinct 
molecules synthesised by HEVs^^^ \^ These include the proteins GlyCAM-1^^^^  ^and
Figure 1.2 : Adhesion molecules involved in Ivmphocvte-endothelial
interactions.
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CD34^. In mucosal lymphoid tissue, L-selectin (along with a^-integrins) binds to 
MAdCAM-1 *^’^  ^and it has been shown in vitro that glycolipids can interact with selectins 
in physiological flow conditions, thus contributing to rolling adhesions^^\ Recently it 
has been shown that a^-integrins can mediate both rolling and adhesion in the multistep 
recruitment of peripheral blood mononuclear cells in vivo and these interactions occur 
independently of the selectins and P2 integrins^. L-selectin is shed following T-cell 
activation^^^ and this may occur during interaction with endothelial cells to allow the T 
cells to migrate. Recent work has shown that the cytoplasmic domain of L-selectin 
interacts directly with the cytoplasmic actin binding protein a  actinin and forms a 
complex with vinculin and ta lin ^ \ The HEV ligands for L-selectin and other putative 
homing receptors have been referred to as ‘vascular addressins’, signifying their role in 
mediating the tissue specific adhesion of lymphocytes expressing the appropriate homing 
receptors. The ligands for E-selectin (E-selectin is present on endothelia), include sialyl 
lewis X (sleX), which is present on neutrophils and macrophages, and there is a similar 
if not identical carbohydrate on a subset of memory T cells^ '^^^. It has been found that 
mice with null mutations in both endothelial selectins (P and E) develop a phenotype of 
leukocyte adhesion deflciency^\ thus providing strong evidence for the functional 
importance of selectins in vivo. Indeed, there is now direct evidence for the presence of 
distinct E- and P-selectin ligands on T-lymphocytes and it has been suggested that y/ô T 
cells may be preferentially recruited to inflammatory sites during the early stages of an 
immune response when P-selectin is upregulated^.
The integrin LFA-1 on blood lymphocytes requires activation for binding to its 
counterstructures ICAM-1 and ICAM-2, which are expressed on HEVs and endothelial 
cells^^'^^\ Binding of I^selectin does not trigger activation of LFA-1, since lymphocytes 
attach and roll in flow on purified peripheral node addressin identically, whether or not 
purified ICAM-1 is present on the substrate. An additional stimulus is required before 
they will arrest and strengthen adhesion through LFA-1^^\ Indeed, recent work has 
shown that chemoattractant stimulation of neutrophils and lymphocytes, rolling on 
immobilised peripheral node addressin (PNAd) and ICAM-1 results in rapid arrest and 
firm sticking in vitro.
G protein-coupled receptors are required for lymphocyte recirculation and are likely to 
provide the signals required to activate the adhesiveness of LFA-1. In relation to this, 
some recent work has shown that transfecting fMLP receptors into lymphocytes and
I
subsequently stimulating the cells with fMLP triggers rapid adhesion via VLA-4 and 
shape change, which is pertussis toxin sensitive^^^\ Pertussis toxin profoundly depresses 
lymphocyte recirculation via the lymphatics, which suggests that G-protein coupled 
receptors of the class are required for lymphocyte emigration through the HEV^°\ 
This is seen in the condition known as ‘whooping cough’, whereby the infectious 
bacterium (Bordetella), secretes copious amounts of pertussis toxin into the blood 
system. One of the effects of this is the subsequent rise in the number of lymphocytes in 
the blood stream due to their inability to traverse the endothelia. Despite the lack of 
emigration, pertussis toxin treated lymphocytes bind normally to lymph node HEVs in 
vitro. These findings provided the basis for an early proposal for a two step model in 
which G protein coupled receptors function subsequent to binding of lymphocytes to
This theory has also been alluded to in more recent in vitro work^^\ which 
implies that cultured HEVs may stimulate lymphocyte motility by two mechanisms: one 
which is rapid and pertussis toxin sensitive and one which is slower, pertussis toxin 
insensitive and dependent on lymphocyte adhesion to the HEVs.
Investigations into lymphocyte-endothelial interactions has shown that functionally 
significant lymphocyte cell surface molecules (CD2, CD44, L-selectin and LFA-1) exist 
as organised complexes in the cell membrane. Redistributions and associations between 
them are triggered selectively by lymphocyte-endothelial cell contact^^\ The enormous 
amount of research in this particular field has ultimately led to the discovery of other 
important molecules involved in lymphocyte-endothelial adhesion. It is now becoming 
clear that the interaction between VLA-4 on the lymphocytes and VCAM-1 is important 
in both constitutive migration of lymphocytes into lymphoid organs and also in immune 
mediated inflammation^'^^^. Another important molecule currently being investigated is 
It has been suggested that in T cells, homophilic CD31 adhesion may be 
primarily involved in transmigration of naive T cells and that its role is complementary 
to that of ICAM-1^^^\ More evidence for the importance of CD31 was shown in a 
recent paper which suggests that it has an important role in the extravasation of natural 
killer (NK) T cells into tissues for constitutive surveillance and into sites of 
inflammation^^^\ Cross linking of CD31 molecules induces cytoskeletal rearrangement 
in human NK cells and this phenomenon is Mg '^*', but not Ca^^ dependent, suggesting 
the involvement of an integrin^^^\ Also both cell spreading and cytoskeletal 
rearrangement, as well as CD31-mediated adhesion appears to be regulated by the 
intracellular cAMP content^^^.
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Another important adhesion molecule on T cells is cutaneous leukocyte-associated 
antigen (CLA)^^\ although theories for its role have yet to become conclusive.
CD44 is a glycoprotein which is found on the surface of most leukocytes including 
lymphocytes and has recently been found to be not necessary for normal lymphocyte 
circulation. However it is required for extravasation into an inflammatory site involving 
non-lymphoid tissue^^°\ In addition, recent evidence has demonstrated that CD44 and its 
alternatively spliced isoforms (CD44R) endow some tumour cells with enhanced 
metastatic ability^^^^\ Recent work has shown that in vitro there is a rolling interaction 
between lymphoid cells and endothelial cells that is not selectin mediated but is in fact 
mediated by
Antigen injected into the tissue of sensitized individuals induces localised accumulation 
of lymphocytes. These lymphocytes (and those accumulating in tissues in autoimmune 
diseases) are almost all memory cells^^ \^ The phenotype of these cells is quite similar to 
that of lymphocytes trafficking through these sites under basal conditions, suggesting that 
the same molecular mechanisms that mediate basal trafficking may be up regulated in 
inflammation. Accumulation of lymphocytes induced by specific antigen or by injection 
of interferon y or TNFa is significantly inhibited by monoclonal antibodies (Mabs), to 
either the LFA-la or the integrin a4 subunit^ ^^ '^ ^^  and almost completely by a 
combination of Mabs to LFA-la and Mabs to E-selectin and VCAM-1 also 
inhibit lymphocyte accumulation in delayed type hypersensitivity in the skin^^\ However 
recent research has shown that this is not the full story and that an ICAM-, ELAM- and
11
VCAM- independent modulation in the early phase of lymphocyte attachment to 
endothelium, seems likely^^\
Therefore, emigration of lymphocytes through peripheral node HEVs, originally thought 
to consist of two steps, has now been shown through recent evidence to require three 
sequential area code signals (L-selectin tethering, chemoattractant activation and 
subsequent integrin activation and binding), that are analogous to those involved in 
neutrophil emigration from the blood stream^^\ Identification of a putative lymphocyte 
chemoattractant secreted by peripheral lymph node HEVs and a chemoattractant receptor 
that is predicted to be selectively expressed on the naive subset of lymphocytes that 
recirculate through peripheral node HEVs will be the subject of intense research interest 
in coming years.
In conditions such as chronic inflammation and cell mediated hypersensitivity, 
lymphocytes make up a substantial part of local infiltrating leukocytes. In inflammation 
the endothelium may exert functions in lymphocyte recruitment from the blood, 
comparable to high endothelium in lymphoid tissues. In fact, HEV-like structures have 
been described in various conditions of chronic inflammation, including autoimmune 
lesions and immune reactivity around tumours^^ '^^^\
Inflammation also affects traffic through the HEVs. Antigen injected into tissue, drains 
to the regional lymph node and greatly increases blood flow to the node and naive 
lymphocyte traffic through the HEV^^^. Furthermore, memory lymphocytes now appear 
to enter the node directly; this is associated with induction of VCAM-1 on non-HEV
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vascular endothélia within the node^^ .^ Entry is inhibited by Mab to the integrin a4 
subunit, and this suggests a role for interaction of VCAM-1 with a4pl^^®\
Recent research has shown that the adhesion molecules topography on the surface of 
leukocytes is a big factor in the outcome of an adhesion cascade^^^\ indeed various 
adhesion molecules are enriched in the uropod region of the polarised lymphocyte, 
particularly ICAM-1 and
The evidence so far, suggests that there are multiple adhesion molecules involved in 
extravasation and that multiple signals are also required for directing activated 
lymphocytes through the endothelia. Thus, a four step or area code model of leukocyte 
emigration from the blood stream, established and validated in vitro and in vivo with 
neutrophils^^^\ appears extendible to all subclasses of leukocytes, including lymphocytes 
(figure 1.1). Combinatorial use of multiple adhesion and chemoattractant receptors in 
the four step model^^  ^with distinct distributions on leukocyte subsets, regulates selection 
of the subclasses of leukocytes emigrating at inflammatory sites and the distinctive 
recirculation behaviour of lymphocyte subsets.
1.3: Lymphocyte chemoattractants
Lymphocyte chemoattractants are interesting candidates for the stage 2 signal for 
lymphocyte accumulation at inflammatory sites. Pertussis toxin treatment inhibits 
lymphocyte emigration in response to antigen^^^\ Identification of lymphocyte 
chemoattractants has been hampered by the low motility of lymphocytes compared with 
that of monocytes or neutrophils. A number of chemokines, all of which were isolated 
based on chemoattractive activity for neutrophils or monocytes or by cloning genes of
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unknown function, have subsequentiy been tested and found to be chemoattractive for 
lymphocyte subpopulations^^^’^ ^^
Chemokines, also known as intercrines, comprise a superfamily of small, secreted 
proteins that mediate inflammation by inducing chemotaxis and activation of a variety of 
inflammatory cells. Members of the chemokine superfamily possess a conserved 
structural motif containing two cysteine pairs. Based on the arrangement of the cysteines 
within this motif, chemokines are divided into two subfamilies. The first cysteine pair of 
the C-X-C chemokines (a-intercrines), are separated by an intervening amino acid, while 
the first cysteine residues of the C-C chemokines (P-intercrines), are adjacent. C-X-C 
chemokines include IL-8 , MGSA, IP-10, ENA-78, platelet factor 4, platelet basic 
protein and thromboglobulin. Members of the C-C chemokine subfamily include MLP-la 
and MIP-ip, MCP-1, -2, -3, RANTES and 1-309. The two chemokine subfamilies 
demonstrate 20-45% homology to each other at the amino acid level and are basic 
heparin binding proteins.
Particular chemokines induce selective migration of leukocyte subsets which differ both 
in phenotypic markers and activation state. This has led to the view that the cellular 
composition at inflammatory sites depends on the combinatorial effects of multiple 
chemokines, each with selective chemotactic activities. For example, while the C-C 
chemokines RANTES, M IP-la and MIP-ip all induce monocyte migration, they have 
distinct chemoattractant properties for lymphocytes. M IP-la induces the preferential 
migration of activated CD8^ T cells and B cells (at higher concentrations the migration 
of these cells seems to be diminished and the migration of CD4^ T cells is enhanced),
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while MIP-ip selectively induces chemotaxis of activated CD4^ T cells^ '^ ^^  RANTES 
induces migration of both activated and resting T cells, including, perhaps most 
significantly, resting memory T cells (CD4^ and CD45R0^)^^^^^\ Furthermore, IL-8 
acts as a chemoattractant for about 10% of human peripheral blood T lymphocytes 
belonging to either the CD4 or CD8 subsets^^ '^^^^ \^ Greater proportions of polyclonally 
activated, than of resting T lymphocytes, exhibit chemotactic responses IL-8^^^'^\ 
Recently, the C-X-C chemokine, IP-10, has been shown to induce chemotaxis of 
activated, but not non-activated, human peripheral blood T lymphocytes^^^\ Phenotypic 
analysis of the stimulated T cell population responsive to IP-10 demonstrated that 
stimulated CD4^ and CD29^ T cells migrated in response to IP-10. This resembles the 
biological activity of RANTES. Recent research has shown that recombinant human IP- 
10 is capable of inducing human T cell migration in vivo and thus provides more 
evidence for its role in inflammation^^^^.
This pattern of selective migration corresponds to the capacity of these chemokines to 
enhance the adhesion of specific subsets of activated T . cells to DL-1 stimulated 
endothelial cells^^^  ^ M IP-la and MIP-ip augment the attachment of activated CD8^ and 
CD4^ T cells respectively^^^\ It has now been reported that there is a new member of the 
C-C chemokine family, termed MlP-ly^^^^, which is produced by dendritic cells and 
recruits T cells before activation.
Moreover, differences in the kinetics of the expression between these chemokines may 
further co-ordinate the regulation of the migration pattern and thus the composition of 
the lymphocyte population at inflammatory sites, at any given time. Chemokines have
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been shown to induce T cell adhesion to purified recombinant human adhesion molecules 
and to extracellular matrix proteins, by stimulating the development of a high affinity 
state in the integrin molecules^"^\ T. Springer’s lab have shown using a transendothelial 
chemotaxis assay with HUVECS (human umbilical vein endothelial cells) on transwells 
that only the C-C chemokines promote transendothelial chemotaxis of PBTLs and that 
the C-C chemokines selectively recruit a memory subset of T lymphocytes^^"^ \^ Also, 
one of his latest papers shows that MCP-1, RANTES and MIP-ip induce T cell binding 
to fibronectin but not ICAM-1, suggesting that the chemokines may be most important, 
not in initiating integrin dependent firm adhesion of T cells to the vascular wall but 
rather in subsequent adhesive interactions during migration into tissue^ '^*^ ^
The endothelium may present chemoattractants to lymphocytes in a functionally relevant 
way, as well as providing a permeability barrier that stabilises the chemoattractant 
gradient. A new concept to emerge recently has been that of specialised chemokine 
binding proteins that act as clearance receptors to remove chemotactic and inflammatory 
peptides from the blood^^^ \^ This reeeptor/protein is also found on endothelial eells and 
thus it could potentially play a role of presenting chemokines to lymphocytes.
Since lymphocytes, responding to specific antigen in tissue, signal emigration of further 
lymphocytes into the site, a chemoattractant was sought in material secreted by mitogen 
stimulated mononuclear cells. Subsequent investigations revealed that MCP-1, previously 
thought to be solely a monocyte chemoattractant, is also a lymphocyte chemoattractant^^^  ^
to an activated subset of memory lymphocytes. There is a clear distinction between the 
IL-8 and MCP-1 responsive T cell populations and that chemokine receptor expression 
on T cells may be regulated with respect to lineage as well as cellular activation^'^^^
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A model of selective chemotaxis has been proposed for the C-C chemokine MIP-ip and 
other chemokines containing glycosaminoglycan binding sites^^\ In this model, 
endothelial cells at inflammatory sites present CDS'*' T cells with a gradient of the 
chemokine immobilised on endothelial surface proteoglycans, such as CD44. The bound 
chemokine triggers functional activation of the lymphocyte integrins, enhancing 
attachment to the vascular endothelium and migration through the vessel into the 
surrounding tissue.
The chemokine receptors, like their ligands, form a family of structurally and 
functionally related proteins. They are members of the superfamily of hepta-helical, 
rhodopsin like, G-protein coupled receptors that can be defined by amino acid sequence 
homologies^^^\ The C-C chemokines bind weakly, if at all, to human neutrophils. 
Nevertheless, M IP-la and RANTES can induce small, transient elevations of 
intracellular calcium that can be homologously and heterologously desensitised by MIP 
l a  and RANTES, but not by other stimuli, suggesting a shared neutrophil receptor^"^’^ ^\ 
However, any functional importance is unclear, since M IP-la and RANTES do not 
induce neutrophil chemotactic or microbicidal responses^^^.
To date, only the lymphocyte MIP-ip receptor (also known as the ACT-2 receptor)^^^ 
has been characterised biochemically, although the relationship of this protein to the 
monocyte receptors is unknown. A distinct receptor for multiple C-C chemokines has 
recently been cloned from monocytes^"^ \^ This receptor, termed C-C CKR-1 induces a 
rapid, transient increase in intracellular calcium, but the binding affinity is not
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necessarily predictive of signal strength. While M IP-la binds to C-C CKR-1 with the 
highest affinity and induces the strongest calcium signal, RANTES transmits a more 
potent signal than MCP-1 and MIP-lp, which bind the receptor with higher affinities. 
Indeed, there are now at least seven human chemokine receptors that bind or respond to 
p-chemokines^^*^® .^ Recent research suggests that chemokines not only share receptors 
but also signal transduction pathways. The signal transduction pathway of MCP-1, 
RANTES and M IP-la are similar, involving pertussis toxin sensitive G-proteins, an 
increase in intracellular calcium, a rapid activation of arachidonic acid release and 
possibly protein kinase activation^^^^'^\
However, it is not only the recently discovered (and much publicised) chemokines that 
are lymphocyte attractants, as other molecules such as interleukins have been found to be 
chemoattractive for lymphocytes. For example, BL-l has been reported to be a potent 
lymphocyte attractant in vitro^^^^\ Its release from the epidermis in disease or following 
injury, may tlierefore constitute an important mechanism for the induction of pathological 
lymphocyte infiltrates. Low level release of epidermal IL-1 under normal conditions may 
also be responsible for physiological trafficking of lymphocytes in normal skin. 
Recombinant BL-6 has also been shown to induce lymphocyte migration in vitro^^'^\ 
Other interleukins which have been reported to have chemotactic activity for T 
lymphocytes include IL-10^“ ’^ \  which is specific for CD8  ^ T cells, IL-2 which is 
reported to be specific for activated CD4^ T cells^ ^^ '^  ^ and IL-15 which has just recently 
been proven to be a chemoattractant for T lym phocytes^^'^^. Furthermore, IL-10 
inhibits the IL-8 chemotactic response of CD4^, but not that of CD8  ^ T cells, as well as 
inhibiting B cell motility induced by IL-4^‘^ °^ . Another paper suggests that IL-1, IL-8 and
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RANTES play important roles by inducing migration of T cells towards sites of 
inflammation, whereas the T cell derived cytokines IL-2, IFN-y, IL-4, IL-10 and IL-13 
seem to be important because of their modulatory effects on T lymphocyte 
chemotaxis^ "^^ .^
Clinical research has shown that IL-2 mediates the regression of certain malignancies, 
but clinical use is limited because of associated toxicities, including parenchymal 
lymphocytic infiltration with multiple organ failure. Recent research has shown that IL-2 
toxicity involves organ-specific TNF-a and RANTES production with increased ICAM-1 
and VCAM-1 expression as potential mechanisms facilitating lymphocytic infiltration and 
organ dysfunction^^\
Recently, a source of T cell chemoattractants has been shown to be neutrophils, which 
upon stimulation with IL-8 release chemoattractants that mediate T-cell and monocyte 
accumulation at sites of inflammation^°\
A lymphokine termed lymphocyte chemoattractant factor (LCF), which has no 
significant homology to any previously described lymphocyte chemoattractants, has been 
identified and cloned^^^^^ and membrane expression of CD4 functions to transmit the 
migratory signal induced by LCF. However, LCF has now been termed as interleukin-16 
and is secreted from serotonin stimulated CD8 '*’ T cells in vitro, therefore serotonin may 
promote recruitment of CD4^ T cells via CD8^ T cells^^^ \^ Eosinophils and CD4^ T 
cells are preferentially recruited into sites of inflammation and in a recent publication it 
was found that eosinophils are a source of two cytokines, IL-16 and RANTES, that are
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chemotactic for both lymphocytes and eosinophils. Their data indicates that eosinophils 
could contribute to the recruitment of CD4^ T cells and more eosinophils^^\ Also, it has 
been found that CD4-lck coupling is essential for IL-16 induced T cell migration^^\
Many more T cell chemoattractants are being discovered lately such as recombinant 
human growth hormone which is capable of inducing significant migration of resting and 
activated human T cells and their subsets^\ A new chemokine, called Mig, which is of 
the C-X-C family has been found and is likely to play a role in T cell trafficking. Also, 
serum amyloid A has been shown to be a T cell chemoattractant^^, as well as 
prostaglandin Ej and leukotriene 64^* .^
It must also be noted that early research in the 1970’s and ‘80’s, reported that T 
lymphocytes are responsive in a chemotactic manner to casein, C5a, f-met-leu-phe and 
denatured proteins^^“ ’^ '^^ ‘^\  Also, P C. Wilkinson has quite recently shown that 
staphylococcal enterotoxin B stimulates motility in T cells over a period of 72 h o u rs^ .
In summary, it is evident that there are many different types of chemoattractants for 
lymphocytes. The diverse binding affinities and signalling potentials that each 
chemoattractant possesses, as well as the differential expression of the chemoattractant 
receptors on target cells, may regulate the combinatorial effect of multiple 
chemoattractants on lymphocytes at localised sites of inflammation.
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1.4î Signal transduction events
In the past few years major advances in our understanding of the signalling pathways 
involved in cell motility have been achieved. Unfortunately, little of this work has been 
done on lymphocytes, instead most cell motility research has tended to concentrate on 
fibroblasts, slime moulds (Dictyostelium discoideum) and neutrophils. Thus some of the 
literature reviewed here will incorporate relevant work done on neutrophils that can be 
considered as similar to the events occurring in lymphocytes.
Polvphosphoinositides. intracellular calcium and protein k inase  C.
Binding of chemoattractants and other agonists to receptors generates intracellular 
signals^^^ '^^^°\ leading to the alterations in the cytoskeleton involved in the motile 
response. Among the many potential signalling events, the two that have received most 
attention are alterations in polyphosphoinositides (ppis), such as phosphatidylinositol-
4.5-bisphosphate (PIP2) and changes in intracellular calcium concentration^^\ There is a 
link between binding of chemoattractants to seven-transmembrane receptors and fluxes in 
ppIs and intracellular calcium. Occupancy of the receptors leads to activation, in a G 
protein dependent manner, of a phospholipase C (PLC), which is specific for
However, it must be noted that there are multiple potential ways of 
regulating the phosphoinositol cycle in lymphocytes and these could also be involved in 
the induction of m o t i l i t y T h e  hydrolysis of PIP2 results in the generation of inositol
1.4.5-triphosphate (IP3) and diacylglycerol (DAG), which has been implicated as a 
second messenger to induce shape change and altered actin polymerisation in 
lymphocytes^^^^\ IP3 binds to specific receptors on intracellular organelles and induces 
the liberation of sequestered calcium, while DAG in conjunction with calcium and
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phosphatidyl serine, activates protein kinase C ( classical isotypes - a , P and y), which 
has been reported to be involved in regulation of the actin network in lymphocytes^^^^\ 
Research in this lab has shown that activation of a serine /threonine kinase, which may 
be a PKC isotype, is necessary for the constant shape changing required for motility of 
lymphocytes^^^°\ Also, activation of a classical PKC isotype maintains lymphocytes in 
the non-motile state and inhibition of the same PKC switches the cell to a constantly, 
shape changing, locomotory phenotype^^^^\ This data suggests that the activation of a 
classical PKC isotype maintains the lymphocytes in a non-motile state. Once this PKC 
isotype has been inhibited, the cells would become motile with the activation of a second 
serine threonine kinase (another PKC isotype or related kinase which is not inhibited by 
the PKC inhibitors). A recent paper has shown the identification of a PKC substrate in B 
cells, known as lymphocyte specific protein-1 (LSP-1), which is an intracellular calcium 
binding protein that binds to F-actin and to the cytoskeleton^^^\
Neutrophil stimulation by N-formyl peptides induces the rapid and transient activation of 
a group of ser/thr kinases^^'^°^\ These kinases exhibit the ability to be renatured after 
polyacrylamide gel electrophoresis and retain their activation state under these 
circumstances. Activation is inhibited by pertussis toxin, but is not induced by phorbol 
myristate acetate (PMA) or blocked by staurosporine. Interestingly, activation of these 
kinases is also blocked by wortmannin and LY294002, inhibitors of PI 3-kinase, 
suggesting that the activities of the renaturable kinases may be dependent on the lipid 
messengers generated by PI 3-kinase^^\ The renaturable kinases remain incompletely 
characterised, with their structure and regulatory properties Still unknown. The 
identification of neutrophil p21-activated kinases, as members of this group of
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renaturable kinases^^^^\ suggests that low molecular weight GTP-binding proteins are 
involved in the regulation of these signalling enzymes. The close correlation between 
activation of the renaturable kinases and acute leukocyte stimulation by chemoattractants 
makes it likely that they are participants in regulating early events in pathways leading to 
activation of the respiratory burst, cytoskeletal assembly and motility.
It is not certain at present, whether lymphocyte motility requires increases in intracellular 
calcium ([Ca '^"'],). For reviews on the role of calcium in leukocyte motility see 
refs. 177,178. It has been demonstrated in neutrophils that it is possible for the cells to 
polymerise actin^^’®®^ and migrate in the presence of very low intracellular calcium levels 
and where transient increases in [Ca^^], are buffered^®Also it has been shown that 
neutrophils in response to chemoattractants can polymerise actin and polarise with very 
low intracellular calcium levels^^^\ Investigations on lymphocytes have also shown that 
Ca^^-mediated signals seem relatively unimportant in motility, whereas PKC mediated 
signals are crucial^^^^\ Recent research has indicated that [Ca^^]| elevation rapidly causes 
rounding and immobilization in T cells^^^\
There is also evidence to suggest that there is a close molecular interaction between 
certain cytoskeletal proteins and a Gja-like protein^^°^\ Specifically, this association 
appears to be required for the activation of PLC that results in IP3 production and 
subsequent internal calcium release.
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TL-2 and IL-15 signal transduction.
However, not all chemoattractants act through G protein linked receptors and thus there 
are other alternative pathways to motility. For example, interleukin-2 which has been 
shown to be a potent lymphocyte chemoattractant^®^\ has a receptor consisting of two 
chains, a  and the latter, which is associated with a number of protein tyrosine 
kinases^ ®^  ^ (PTK). IL-2 induces strong tyrosine phosphorylation of PI 3-kinase, Raf, She 
(src homology 2 domain containing protein) and Vav in T cells^® '^^\ as well as 
activating p21 ras via a Products of the PI 3-kinase^ ^^ ^^  induced phosphorylation
of membrane ppis, such as PIP3, have been suggested as one possible signal for 
induction of cytoskeletal changes^^^\ thus this could be one possible pathway (one of 
many!) for the induction of motility in lymphocytes by IL-2. Recently it has been 
discovered that both IL-2 and IL-15 which cause motility in T lymphocytes, have been 
found to cause tyrosine phosphorylation of proteins termed Janus kinases 1 and 3 (JAK-1 
and -3) and also of STAT3 and STAT5^^^’^ ^^  ^ (signal transducer and activator of 
transcription), which are members of the ST AT family of transcription factors, 
downstream effectors of the JAK kinases. Also, another group found that IL-2 caused 
tyrosine phosphorylation of STAT3 and that herbimycin A blocked the nuclear 
translocation of STAT3^^\ IL-2 and IL-15 cause tyrosine phosphorylation of insulin 
receptor substrates (IRS)-l and -2 in T cells and JAK-1 and JAK-3 associate with IRS-1 
and -2 in T cells. This suggests that IRS-1 and -2 may be important docking molecules 
recruited in response to IL-2 and IL-15 in T lymphocytes^^^\
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IL-2 has also been found to induce expression, translocation and association of PKC-^ to 
a structure coincident with the actin cytoskeleton. Furthermore, PKC-Ç has a role in 
maintaining the integrity of the actin cytoskeletal structure in IL-2 stimulated cells^^^\ 
IL-8 which has been shown to be a chemoattractant for lymphocytes^^°'^  ^ causes 
activation of phospholipase-C and -D in T lymphocytes^®^.
Small molecular weight GTP-binding pro teins.
Recent cell motility research has focused on the pathway involving activation of the 
small molecular weight GTP-binding proteins^ ^^ ®'^^ ’^^ ^^ ’^ ^^  ^ ras and rho in cytoskeletal 
regulation. For example ras inhibition suppresses fibroblast migration towards PDGF- 
gg(266) According to this schema, activation of ras via receptor coupled heterotrimeric 
GTP-binding proteins or via, as yet, unidentified tyrosine kinases binding to growth 
factor binding protein-2 (GRB-2) and SOS, leads to alterations in the cytoskeleton^^^'^\ 
Although unconfirmed in lymphocytes, these pathways seem to be highly conserved so 
that data from other species and cell types are likely to be applicable. Research into ras 
in lymphocytes has shown that it is activated within minutes upon the cell being 
stimulated by mitogens and that this activation is apparently dependent upon PKC 
activation^^^\ In particular, rho A (a member of the rho family), has been implicated in 
growth factor induced formation of stress fibres and focal adhesions, whereas rac (a 
member of the rho family of small molecular weight GTP binding proteins) has been 
implicated in the formation of membrane ruffles^^’^ .  Also, it has been shown that rho 
induced stress fibre formation is dependent on PKC activation and that rho-induced 
activation of a tyrosine kinase is required for the formation of stress fibres^^\ Rho A 
activation downstream of PKC is involved in LFA-1 activation and aggregation^^°^^
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Furthermore, microinjection of antibodies to GRB-2, block growth factor induced 
membrane ruffling and lamellipod formation in cultured epithelial cells^^ ®\ thus linking 
upstream events close to, or at the level of the receptor with the downstream events 
resulting in cytoskeletal reorganisation. It must be stressed at this point that since 
lymphocytes do not express as many stress fibres as other cell types, such as fibroblasts, 
then if these small molecular weight G-proteins do play a role in lymphocyte motility, it 
is most certainly through rac rather than rho. However, recent work has shown that in 
lymphoid cells transfected with chemoattractant receptors, agonist stimulation activated 
rhoA in seconds and inactivation of rho by C3 transferase exoenzyme blocked agonist 
induced lymphocyte a4pl adhesion to VCAM-1, suggesting that rho participates in 
signalling from chemoattractant receptors to trigger rapid adhesion in leukocytes^^^^\
Recently it has been reported that CDC42, another member of the rho family, triggers 
the formation of filopodia, a third type of actin-based structure found at the cell 
periphery. Activation of CDC42 in Swiss 3T3 cells leads to the sequential activation of 
rac and then rho, suggesting a molecular model for the co-ordinated control of cell 
motility by members of the rho family of GTPases^^\ Another possible mechanism for 
the control of actin polymerisation by rho-like GTPases is suggested by the recent 
identification of WASP, the protein implicated in the Wiskott-aldrich immunodeficiency 
syndrome, as an effector of CDC42. Overexpression of WASP in a variety of cell lines 
causes ectopic actin polymerisation at sites that are enriched in WASP and this 
reorganisation of the actin cytoskeleton is CDC42 dependent^^^^\ In a separate study, 
activation of CDC42 was also shown to cause F-actin reorganisation and co-localise with 
the 85kDa regulatory subunit of PI 3-kinase^^^\
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Between the initial receptor and the rho family member in the signal transduction 
pathway, specific kinases may be required. For example, PI 3-kinase is required for the 
activation of rac by the binding of agonists to tyrosine receptors^^'^^\ However, PI 3- 
kinase is not required by agonists that induce ruffling via heterotrimeric G proteins, nor 
is it required for induction of ruffling by A recent paper has shown that both
GTP- and GDP-bound rac-1 associate with phosphatidylinositol-4-phosphate 5-kinase in 
vitro and in vivo. ¥l 3-kinase also bound to rac-1 and CDC42Hs, and these interactions 
were GTP-dependent. This suggests that the effects of rho family members on the actin 
cytoskeleton are mediated in part by phosphoinositide kinases^^^. Other data 
demonstrates that rho regulates 4 ,5-PIP2 synthesis and indirectly, 4 ,5-PIP2 hydrolysis. 
They also raise the possibility that PIP2 synthesis could mediate the effects of rho on the 
actin cytoskeleton^. Another paper shows that the induction of arachidonic acid release 
and leukotriene production is one of the major biochemical pathways by which rac can 
influence the cytoskeleton^*^\
A ser./thr. protein kinase called protein kinase N is a target downstream of rho-GTP and 
may therefore be also involved in m otility^\
Regulation of small molecular weight GTP-binding proteins
Immediately upstream of each rho family member, a guanine nucleotide exchange factor 
(GEF) is apparently needed^^. The family of GEFs for rho family members share 
common motifs, namely a Dbl homology region, which has GEF activity and a pleckstrin 
homology domain, which can bind PIP2 and the py subunits of heterotrimeric G 
proteins^ ^*®. A GEF can have specificity for a particular member of the rho family.
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Thus, transfection of fibroblasts with Tiam-1, a GEF for rac and CDC42, stimulates 
membrane ruffling presumably by activating rac^^^.
So far, the downstream elements of pathways that regulate cytoskeletal organisation have 
not been defined. The list of activities stimulated by CDC42, rac and rho is long and 
includes cascades of kinases that regulate gene transcription and cell growth^^^\ But, 
none of these activities have been linked to F-actin rearrangements. CDC42 and rac 
directly activate ser./thr. kinases of the p65^^ family (kinases homologous to STE20 of 
yeast and pl20^^^ of rats)^^^ \^ However, in neutrophils, inhibition of PI 3-kinase with 
wortmannin inhibits chemoattractant activation of p65^"^ and NADPH oxidase, but does 
not inhibit membrane ruffling^^^\ Thus, activation of this particular PAK is not needed 
for membrane ruffling. A tyrosine kinase appears to be required downstream of rho for 
the formation of stress fibres, as rho mediated induction of stress fiber formation in 
Swiss 3T3 cells is inhibited by the tyrosine kinase inhibitor genesteW^\
Also interacting with the rho family are proteins which can negatively regulate their 
activity by increasing the hydrolysis of their bound GTP; these negative regulators are 
the GTPase activating proteins or GAPs^ ^^ '^^ ^®\
A target of the B cell receptor - induced tyrosine phosphorylation is pl90^^°^\ a GAP for 
rac and rho^^° \^ These ras proteins are important regulators of the actin network^^'^, 
suggesting that the tyrosine phosphorylation of p i90 may influence microfilament 
behaviour. Interestingly, Vav, which has been implicated in regulating ras^ ®^^ \ has 
homologies to a GEF for rho in yeast, suggesting that it may also regulate rac and rho in
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lymphocytes. It may be that the phosphorylations of p i90 and Vav lead to co-ordinated 
actions on rac and rho, for example, by inhibiting p i90 action and stimulating Vav 
action or vice versa. In addition, it seems that there are multiple functions for the 
rhoGAP family members p i90 and bc/^^^ (product of the breakpoint cluster gene), 
which may enable them to co-ordinate a network of signalling pathways linking protein 
tyrosine kinases^ ^^ ^^  to different rho family proteins and other GTPases involved in 
mediating organisation of the actin cytoskeleton in response to extracellular signals. 
Another regulatory molecule in this schema is rhoGDI (GDP dissociation inhibitor - this 
blocks the effects of GAPs and GEFs), which is an inhibitory GDP/GTP exchange 
protein for the rho family, although it can interact with rac p21 also. It has been shown 
that the rhoGDI protein is an integral part of the system that regulates cell motility in 
fibroblasts^^ presumably through the microfilament system. More detailed data has 
shown that the complexation of rhoGDI with both GDP and GTP bound forms of rac^ ^^ ^^  
can be regulated by certain lipids generated in chemoattractant stimulated cells and thus 
this would be a path by which chemoattractants can cause actin regulation^^^" \^ Recently 
a rho-GDI was identified that was specifically expressed in lymphocytes and is 
downstream in the signalling cascade resulting from PKC activation^^^^\ In addition, a 
lymphocyte protein was identified that has striking homology to a number of regulatory 
rho-like proteins, that affect motility^^^^.
Thus, the evidence is quite strong that rho can regulate actin microfilament 
organisation/assembly, although this has not been established in chemoattractant- 
stimulatcd leukocytes. Polymerisation of neutrophil actin can be induced by guanine 
nucleotides in permeabilised cells^®^\ and both rho and rac have been shown to regulate
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the state of the actin cytoskeleton in mast cells^ ^®^ \ As with rho-induced actin assembly 
in stress fibres, little is known about the mechanisms by which rac regulates actin 
assembly associated with ruffling/cell motility, and there is no evidence yet that rac has 
similar effects in chemoattractant-stimulated leukocytes. However, it seems quite likely 
that these small molecular weight GTP-binding proteins and their regulatory counterparts 
play a significant role in the signal transduction of lymphocyte motility.
Role of the second messenger cAMP.
The role of cAMP (cyclic adenosine mono-phosphate), in transduction of motility is 
rather unclear so far, however recent research is indicating that an increase in 
intracellular cAMP ([cAMPjJ concentration inhibits lymphocyte motility^^^^'^^\ and 
affects their adhesiveness^^^\ Elevation of [cAMP], induces a decrease of cellular 
filamentous actin and a stabilisation of microtubules^^^\ How increases in [cAMP], 
modulate the cytoskeleton is unknown but it could be via control of putative actin 
binding proteins, or it could be through intervention of transduction pathways that 
control cytoskeleton organisation. For example, it has recently been shown that cAMP- 
dependent protein kinase A (PKA) directly phosphofylates actin and reduces its 
polymerisability. In contrast, protein kinase C mediated phosphorylation of monomeric 
actin increases its polymerisability, thus having the opposite effect of PKA on actin^^^\ 
A recent study has shown that phosphodiesterase inhibitors inhibit the migration of 
human T lymphocytes by increasing the [cAMP], concentration^^®^^
Lymphocytes and their preeursors are eells whose locomotor capacity varies at different 
stages of maturation or activation^^^^\ A model has been proposed by P.C.
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Wilkinson^^^^\ in which the two stages of lymphocyte locomotor activation can be seen 
as follows:- (a) acquisition of locomotor capacity which is growth determined, occupies 
a period of hours and may need expression of new genes; and (b) response by 
polarisation and locomotion to a chemoattractant, similar to the response of neutrophils 
and taking only minutes. These two stages can be distinguished pharmacologically. Two 
immunosuppressant drugs, cyclosporin and FK506, specifically inhibit mitogen activated 
lymphocyte growth, acting early in Gp These drugs inhibit the cell cycle related 
acquisition of locomotor capacity in lymphocytes^^^ '^^^®\ but have no effect on the 
locomotor responses of already motile lymphocytes. Conversely, pertussis toxin has no 
effect on the acquisition of locomotor capacity but does inhibit the immediate response of 
lymphocytes to IL-8 and fetal calf serum^^^ \^ their locomotion in filter assays^^^ and 
their entry into lymphoid tissues^^^\ These observations suggest separate transduction 
pathways, one mediated by a pertussis toxin-sensitive G protein for chemoattractant 
induced lymphocyte motility; the other for growth activation and locomotor activation, 
the pathway for which is probably not directly mediated by a pertussis toxin-sensitive G 
protein.
Thus the second messengers involved in transduction of motility are beginning to emerge 
but it is clear that much of it is yet to be discovered and that factors such as state of 
lymphocyte activation and maturation are going to be important parameters in the signal 
transduction pathways used.
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1.5: Actin Modulation
Whatever the nature of the molecular signal or signals, exposure to chemoattractants 
leads to highly ordered and spatially localised changes in the actin cytoskeleton that are 
directly responsible for lamellar protrusion and cell motility^^^ '^^^ '^^^\ The control of the 
cellular microfilament system is mediated by second messengers through various actin 
binding proteins which have certain actin modifying functions. Actin polymerisation is 
correlated with protrusive activity in almost all cell types along with filament cross 
linking and filament severing.
There is very little literature published in the field of lymphocyte motility in connection 
with actin modulation by second messenger systems. I have thus included reports of 
systems that have been found in other cell types as it is thought that these systems are 
fairly conserved throughout evolution, they are therefore, of relevance to lymphocytes.
Recent studies have highlighted the importance of thymosin-P4 in regulation of the 
leukocyte cytoskeleton^^^^^^®\ These cells contain up to 250pM of this protein, which 
quantitatively is sufficient to account for the majority of actin monomer sequestration. 
Consistent with this function, increasing intracellular levels of thymosin-P4 by either 
microinjection or by over expression in transfected cells reduces the amount of 
filamentous actin by decreasing the effective cytosolic concentration of actin monomers. 
This ultimately promotes monomer release from filament ends^^^ \^ More importantly, 
thymosin-P4 can release monomer rapidly, thus large amounts of monomer can be 
released from this source in response to signals for filament assembly. There are two 
other notes to add about this important actin monomer binding protein. First, thymosin- 
P4 inhibits exchange of adenine nucleotide bound to actin monomer. Second, thymosin-
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P4 has a 50-fold greater affinity for actin monomer bound to ATP (G-actin-ATP), than 
for monomer bound to ADP (G-actin-ADP). Therefore, monomer release from 
thymosin-P4 may be facilitated by exchange of ADP for ATP, by a local decrease in the 
ATP/ADP ratio, resulting from the activity of second messenger systems that have ATP- 
consuming activity. According to this scheme, the polymerisation of actin might in fact 
involve addition of ADP-actin monomers to filaments^^^\
Profilins are a group of 15kDa molecular weight basic proteins^^^^’^ "^^^ that are present in 
two interconvertible states; a high affinity state that binds actin monomers tightly and a 
low affinity state^ "^*®^ that may function to sustain high rates of filament assembly at the 
barbed end. Profilins can inhibit ATP hydrolysis by monomeric actin and speed 
exchange of ADP for ATP, thus facilitating microfilament assembly^^^^. It is noteworthy 
that membrane ppis including PIP and PIP2, lower the affinity of both forms of profilin 
for G-actin^^^’^ ^^  ^ and that the levels of these ppis are altered in response to 
chemoattractants providing a potential mechanism for dynamic regulation of actin 
assembly. The interaction between profilin and PIP2 prevents the hydrolysis of PIP2 by 
the phosphorylated form of Phosphorylation on tyrosine (by a receptor
tyrosine kinase for example), of PLC-y, allows the lipase to overcome profilin inhibition 
and to hydrolyse PIP2. While profilin seems to be able to regulate the activity of PLC-y 
and to make it dependent upon tyrosine phosphorylation for activation, the hydrolysis of 
PIP2 by activated PLC-y may, in fact regulate the interaction of profilin with actin^ '^^ \^ as 
the subsequent binding of PIP2 to profilin inhibits the interaction between profilin and 
actin. Therefore, PIP2 turnover may link receptor tyrosine kinase activation (or any other 
system that can activate PLC-y) with actin network reorganisation, by modulating the
33
availability of profilin, as the concentration and distribution of PIP2 is altered in response 
to chemoattractant stimulation. There is also evidence to suggest that profilin is 
phosphorylated by PKC and that this phosphorylation is stimulated by PIP2^ ^^ .^ In 
addition it has recently been shown that DAG, a product of PIP2 can directly enhance the 
formation of actin nuclei at the membrane level by activating a nucleating protein 
factor^^^\ which is yet to be characterised. Small GTP-binding proteins like ras also 
have the ability to regulate inositol phospholipid metabolism^^^®\ It is possible that 
regulation of the actin network by small GTP binding proteins requires specific 
modulation of the local inositol phospholipid concentration at the membrane level^^^ \^
The ability of proteins to bind to actin filaments and prevent monomer exchange is 
termed capping and leukocytes contain several such proteW^^®\ Those that cap the 
barbed ends result in net filament depolymerisation. Gelsolin, an 82kDa protein, is able 
to bind to the barbed end of filaments and prevent monomer exchange as well as to sever 
filaments in a calcium dependent manner^^^^\ Gelsolin is also able to bind actin 
monomers, an interaction that is decreased by interactions with membrane ppIs^ ^^^V For 
example, exposure of neutrophils to fMLP, decreases the number of gelsolin-G-actin 
complexes^^^^\ A function of gelsolin that appears to be important in motility is its 
ability to sever filaments in a calcium dependent manner^^^^\ Hence gelsolin is under 
dual regulation: calcium promotes its binding to actin, its severing of actin filaments and 
its blocking of monomer addition at the fast growing filament end - all effects leading to 
actin depolymerisation and to the solution of a cross-liked actin gel. Therefore it follows 
that the reversal of gelsolins tight binding to actin must be essential for assembly of the 
pseudopodial network. Thus, ppis could be responsible for this reversal, with the
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implication that gelsolin, which is regulated by the two known intracellular messengers 
(calcium and an intermediate of the phosphoinositide cycle), and is thus positioned as an 
integral component between second messenger systems and actin network regulation.
Other actin regulatory proteins include cofilin and destrin. Cofilin has the ability to bind 
along the side of F-actin and to depolymerise F-actin in a pH-dependent manner. Various 
ppis inhibit the actions of cofilin in a dose dependent manner, while IP3 has no effect on 
them^^^ .^ Furthermore, in the same study destrin, a pH independent actin depolymerising 
protein and deoxyribonuclease I, a G-actin-sequestering protein, were also functionally 
inhibited by ppls. Thus it seems that the sensitivity to ppIs may be a common feature 
among actin binding proteins which can regulate the state of actin polymerisation. In 
recent years, a lymphocyte specific actin binding protein, termed LSP-1 was identified 
that only binds F-actin and is thought to be involved in mediating cell motility^^^^\ 
However, this protein has now been found to be not lymphocyte specific but is present in 
all human leukocytes^^^.
There are inevitably numerous more actin regulatory proteins and it must be stressed that 
apart from the microfilament network, there is also the microtubule and intermediate 
filament network which in some way are involved in cell movement^^^ '^^^^\ Although the 
general opinion is that fundamentally the initiation of shape change and motility is mostly 
controlled by actin^ ^^ ^^ ’ as it has been shown that in lymphoma cells , a high level of actin 
polymerisation is a prerequisite for the formation of pseudopodia and infiltration of the 
cells into tissues^ ^^®\ Interestingly, rac has recently been found to interact with tubulin 
and this may have a role in controlling changes in ceU morphology^^^\ Also, a new
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unconventional myosin termed myosin IXb has been discovered with the highest levels in 
peripheral blood T lymphocytes^*^>. The tail region was found to contain a putative 
GTPase activating protein (GAP) domain of the rho/rac family of ras-like G proteins, 
suggesting a role for this myosin in actin-based processes in lymphocytes.
The actin regulatory proteins just described may be regulated by several different
signalling pathways and stimulated pseudopod extension in lymphocyte motility will
undoubtedly involve crosstalk between specific receptors and signal transduction 
systems.
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1.6 î Aims of the project.
The aim of this project was to elucidate whether there is a final common signal 
transduction pathway utilised by all agents that causes induction of motility in T 
lymphocytes. Therefore, this is an investigation into the penultimate step of the “four 
step model of lymphocyte transendothelial migration” (see fig. 1.1), in which the 
lymphocyte first changes shape.
The first step in investigating this question was to develop a model whereby freshly 
isolated peripheral blood T-lymphoeytes (PBTLs) eould be indueed into a motile state by 
a number of agents. Therefore, agents will be tested for their ability to induce motility in 
PBTLs and once a number of these have been found, then the second messenger 
elements that they utilise will be examined in an attempt to observe whether there are 
any common signal transduction elements. If any common second messengers are found, 
then these would be contenders for part of a motility signal transduction pathway.
As well as investigating motility in PBTLs, a human lymphoid cell line, termed MOLT-4 
cells will also be investigated as above. Two population variants of this cell line were 
available, a motile and non-motile population and differences between the two 
populations shall also be investigated.
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2. Materials and Methods
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2.1; Cells and media.
The MOLT-4 lymphoid cell line was obtained from ECACC (Porton Down, U.K.), and 
maintained in growth media which constituted RPMI-1640 (Gibco BRL, Life 
Technologies Ltd., Paisley, U.K.), with 10% fetal calf serum (heat inactivated, 
mycoplasma and virus screened), lOmM HEPES buffer, 2mM L-glutamine, 50 lU/ml 
penicillin and 50 pg/ml streptomycin, all obtained from Gibco. The cells were grown at 
37°C. Motile and non-motile variants of MOLT-4 were isolated as described in ref. 131. 
In isolating peripheral blood T lymphocytes, a medium consisting of all the above but 
substituting the fetal calf serum with 2.5% human serum albumin (fraction V powder, 
96-99% albumin. Sigma, U.K.), was used (2.5% HSA).
2.2: Solutions and buffers.
All materials from Sigma, U.K. unless otherwise stated.
Phosphate buffered saline (PBS) was prepared using deionised water (dH20 ) and PBS 
Dulbecco A tablets (Unipath Ltd., Basingstoke, U.K.). The composition being, NaCl 
(8g/L), KCl (0.2g/L), disodium hydrogen phosphate (1.15g/L), potassium dihydrogen 
phosphate (0.2g/L). pH 7.3
Balanced salt solution (BSS) was prepared in dH20  by dissolving NaCl (8g/L), KCl 
(0.4g/L), CaCl2 (0.14g/L), MgCl2.6H20  (0.2g/L), glucose (Ig/L), HEPES (2.388g/L) 
and adjusting to pH 7.4. All constituents were obtained from BDH Ltd., Glasgow, U.K.
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Laemmli’s sample buffer (Ix) : 62.5mM Tris-HCL, pH 6 .8 , 4% sodium dodecyl 
sulphate (SDS) (BIO-RAD, U.K), 5% P-mercaptoethanol, 8.5% glycerol, 2.5mM 
orthovanadate, lOmM paranitrophenylphosphate, 12^g/ml leupeptin, 12^g/ml aprotonin, 
1.25mM PMSF, 0.025% bromophenol blue (BIO-RAD).
Western blot buffer : (2L) 70g glycine (BDH), 1.5g SDS, 24g tris-base, l,600mls 
(IH2O and 400mls methanol (Fisher Scientific, Loughbrough, U.K)
Upper gel buffer : 500mls (IH2O, 30.25g tris-base, 2g SDS, 0.74g sodium EDTA, pH 
6.8
Lower gel buffer : 500mls dH2 0 , 90.75g tris-base, 2g SDS, 0.74g sodium EDTA, pH 
8.8
Runnmg buffer : 5L dH^O, 15g Tris-base, 72g glycine, 5g SDS.
Gel destain solution : IL (IH2O, IL methanol and 200ml glacial acetic acid.
Gel overlay solution : 20ml methanol, 200mg amido black, 80ml (IH2O.
Coomasie blue stain : 2.2g Coomasie blue, IL methanol, IL (IH2O and 200ml glacial 
acetic acid.
40
2.3: General reagents.
AU reagents were from Sigma (U.K.) apart from the foUowing:
Bisindolyhnaleimide GF109203X (Bis.) (Calbiochem, U.K), Human recombinant 
Interleukin-2, MIP-la, MIP-ip, RANTES, MCP-1, Interleukin-8 , Interleukin-la. 
Interleukin-10, PDGF, EGF and TNFa are aU from R&D systems (U.K). Interleukin-15 
(Peprotech, USA). AU amUoride compounds were from Research Biochemicals 
International (USA).
2.4: Isolation of human peripheral blood T-Lymphocytes 
(PBTLs).
Whole blood was obtained by venepuncture from healthy donors and anticoagulated by 
mixing with heparin at approximately 1-2 U/ml whole blood. After dUution 1:1 with 
PBS, 4ml volumes of the dUuted blood were layered onto 3ml of ficoll-paque (Pharmacia 
Biotech, Sweden) in plastic, conical-based tubes. After centrifugation for 40 mins. at 
400g, the mononuclear ceUs layer at the interface of the separation media was then 
coUected by pasteur pipette and the mononuclear ceUs washed (z. e. resuspended in 20ml 
PBS and centrifuged 5-10 minutes at 400g) twice. Typically 1-2x10^ mononuclear cells 
were obtained per ml of blood. The ceUs were then resuspended at 1x10^ cells/ml in 
2.5% human serum albumin (HSA). Then 1ml of the cell suspension was put in each 
plastic eppendorf tube (1.5ml volume) and to this was added lOOpl of both mouse anti­
human CD19 and CD 14 monoclonal antibodies (murine IgGlic, 200 tests/2ml, Serotec, 
U.K.). The mixture was then mixed by rotation on a rotar wheel at 25 revolutions per
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minute at room temperature for 30 minutes. The cells were washed twice in 2.5% HSA 
and resuspended at 4xl0^cells/ml in 2.5% HSA. An equal volume of pre-washed goat 
anti-mouse IgG coated Dynabeads (DYNAL, U.K) was added before mixing for 30 
minutes at room temperature on a rotar wheel as before. The contaminating B cells and 
monocytes with the attached magnetic beads were then removed using a Dyna-magnet 
(DYNAL). The remaining T cells had a mean purity of 92% with <2% monocyte and B 
cells as shown by fluoresence flow cytometry (data not shown). This method was 
derived from reference 53
2.5: Cell polarisation assay.
The cells were resuspended at IxlOVml in the relevant media (10% PCS for MOLT-4 
cells and 2.5% HSA for PBTLs) and 90pl of cell suspension was added to each well of a 
96 well cluster plate. The plate was then incubated 20 minutes at 37°C, 5% CO2, before 
addition of lOpl of a lOx working concentration of the test reagent. After which the plate 
was incubated for 1 hour at 37°C, 5 %C02 . Cells were then fixed in a final concentration 
of 3.7% formaldehyde/PBS and then assessed microscopically, under 400X 
magnification, for the percentage of irregular, shape changed cells. The criterion for 
non-shape changed cells was that at least three-quarters of the cell approximated to a 
circle. Each experiment was set up in triplicate and results expressed as the mean % 
shape changed cells ± standard error of the mean (SEM). Since some of the test reagents 
were made up as stock solutions in dimethyl sulphoxide (DMSO), solvent controls were 
incubated in all assays. With the data shown in the RESULTS section, the corresponding 
concentrations of solvent were without effect.
This method was derived from and validated in previous literatwe^ ^^ ® *^,
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2 .6: Time-lapse video microscopy
Cells were suspended in the relevant media (5xl0^cells/ml), with ImM HEPES and 
placed in the wells of 96-well cluster plates which were then sealed with tape to prevent 
evaporation. The cluster plate was placed on the stage of a Zeiss Axiovert 35 microscope 
and maintained at 37°C by means of a thermostatically controlled fan heater. For video 
analysis a Panasonic WV-BL600 camera was used with a Panasonic time-lapse video 
cassette recorder. Recordings were made over 1 hour and replayed at x 160.
2.7: Transmigration assay™.
For studies on PBTLs, Costar transwells (Cambridge, U.K.) of 24 well size with 6.5mm 
diameter polycarbonate filters and a 3pm pore size were used. Freshly isolated PBTLs 
were resuspended at 5x10^. cells/ml in 2.5% HSA media. Then, lOOpl of the cell 
suspension was added to the upper chamber of a Costar transwell insert. The insert was 
immediately placed in the well of a 24 well cluster plate containing 600pl of 2.5% HSA 
with the relevant concentration of the test reagent. Control wells contained only 2.5% 
HSA with no reagent. The plate was then incubated for 4 hours at 37°C, 5% CO2, after 
which the inserts were removed and the cells in the lower wells were fixed in a final 
concentration of 3.7% formaldehyde/PBS. The number of cells in the lower chamber was 
determined with the use of a Neubauer counting chamber. For each test reagent 
concentration, triplicate wells were set up and the results were expressed as the 
percentage cells transmigrated compared to die initial number of cells added to the 
transwell.
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In experiments with MOLT-4 cells, the protocol was similar except inserts with 8pm 
pores were used.
2.8: Intracellular calcium measurements^^^
Measurements of intracytoplasmic free Ca^  ^ levels were performed with FURA-2/AM 
(Molecular Probes, USA.). Freshly isolated PBTLs or MOLT-4 cells were washed twice 
in BSS. The cells were then resuspended at 2.5 x lOVml in BSS with a 5pM final 
concentration of FURA-2/AM and incubated at 37°C in a water bath for 45 minutes (in 
the dark) with occasional mixing. FURA-2/AM was obtained as special packaging in 
50pg aliquots, which were reconstituted in DMSO to produce a 5mM solution.. After 
incubation the cells were washed once in BSS and resuspended at 1.5 x lOVml in BSS. 
The cells were kept in a water bath at 37°C before the experiments were started. A 2ml 
aliquot of the labelled cells was then transfered into a quartz cuvette and inserted into the 
spectrometer. Fluorescence of the cellular suspension was monitored with a Perkin- 
Elmer LS-50B luminescence spectrometer in quartz cuvettes thermostatically controlled 
at 37°C. Fluorescence of the cellular suspension was first done with unlabelled cells to 
correct experimental measurements for autofluorescence. The cell suspension was excited 
alternately and 380 nm and the fluorescence measured at 510 nm. Ten nanometer slit 
widths were used for both excitation and emission. After stabilization of the baseline, 
stimuli were added in small volumes (typically 20pl).
Graphic representations of [Ca^ ]^; were computed by using the equation:
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[Ca '^ l^i = 224 X (R - Rmin)/(Rm» - R) X Sf380/Sb380, previously published by 
Grynkiewicz et R^u^ x and R^ jn were evaluated in ImM Ca^  ^ - containing media
(BSS) by perforating the cells with lOpM ionomycin for R^^ followed by the addition of 
an excess of EGTA at 5mM for R^ ûn-
2.9: Intracellular pH (pH,) measurements*^”*.
Measurements of pH, were performed with BCECF/AM (Molecular Probes, USA). 
Freshly isolated PBTLs or MOLT-4 cells were washed twice in BSS and the cells then 
resuspended at 2.5 x lOVml in BSS with a final concentation of 5pM BCECF/AM and 
incubated at 37°C in a water bath (in the dark) for 30 minutes, with occasional mixing. 
BCECF/AM was obtained as special packaging in 50pg aliquots, which were 
reconstituted in DMSO to produce a 5mM solution. After incubation the cells were 
washed once in BSS and resuspended at 1.5 x lOVml in BSS. The cells were then kept in 
a water bath at 37°C before the experiments started. A 2ml aliquot of the labelled cells 
was then transfered to a quartz cuvette and is inserted into the Perkin-Elmer LS-50B 
luminescence spectrometer. Fluorescence of the cellular suspension was first done with 
unlabelled cells to correct experimental measurements for autofluorescence. Excitation 
wavelengths were adjusted alternatively to 440, or to 490 nm, while the emission 
wavelength was set to 530 nm. Ten nanometer slit widths were used for excitation and 
5nm slit Width used for emission.
After stabilization of the baseline, stimuli were added in small volumes (typically 20pl). 
Calibration of pH; in cell suspensions in situ is difficult and erroneous, since it is nearly 
impossible to change the buffer (and thereby the pH) witiiout losing or damaging tiie
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cells^^. Therefore, ratios were calibrated by external measurements using BCECF free 
acid (IpM) (Molecular Probes, USA), in intracellular buffer titrated to different pH 
values between 6 .6  and 7.4 (intracellular buffer consisted of llOmM KCl, lOmM NaCl, 
2mM MgClz, 5mM KH2PO4, 2mM dithiothreitol. 2mM EGTA, 1% BSA and 20mM 
HEPES - all constituents obtained from BDH, Glasgow, except BSA and EGTA which 
were from S i^ a ) .  The ratios plotted against pH resulted in a highly linear correlation, 
with correlation coefficients > 0.98. A typical calibration curve is displayed in figure 
2.1. This method of pH calibration has been validated previously in ref. 297.
Figure 2.1 : Correlation between 490/440 nm ratio of BCECF 
and pH
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2.10: D-iwvo-Inositol 1.4.5-trisphosphate (IP,) assay*^^
Assays were conducted using the fHJIPj binding assay kit provided by Amersham 
International following the instructions provided.
Fresh PBTLs were isolated and resuspended in 2.5% HSA at a concentration of 
5xlOVml. 500pl of the cell suspension was then aliquoted into each 1.5ml eppendorf tube 
and small volumes of the agonist were then added to the cells for 1 minute at 37°C. The 
incubation was terminated by addition of 500pl ice cold 10% perchloric acid. After 
leaving 10 minutes on ice, the samples were centrifuged for 5 minutes at 2,000g. 400pl 
of the supernatant from each sample was transferred to a separate tube containing lOOpl 
of lOmM EDTA, (pH 7.0).
The samples were neutralised by adding 300pl of a 1:1 (v v) mixture of Freon (1,1,2- 
trichlorotrifluoroethane) and tri-n-octylamine, followed by vigorous mixing of the 
separate phases on a vortex mixer. After centrifugation for 1 minute at 2000g, three 
-phases were obtained. The upper phase was the neutralised sample plus all the water- 
soluble components. A 400pl portion of the upper phase was removed for use in the IP3 
binding assay kit, which is based on the ability of IP3 in the sample to displace fixed 
amounts of pH]IP3 from the IP3 receptor. A standard curve was constructed in the range 
0.2 to 25 pmol and displacement values obtained were converted to pmol IP3 by the use 
of this curve.
2.11; Preparation of acrvlamide gels^ ”^ .^
10% acrylamide mini gels were made as follows using a Biorad minigel apparatus.
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To a 50ml tube is added 8ml of lower gel buffer, 13.1ml dH2 0 , 10.7ml 30% (w/v) 
Acrylamide/Bis-acrylamide stock solution (Anachem,U.K.), 200|ils 10% Ammonium 
persulphate and 20pls TEMED (BIO-RAD). After gentle mixing the solution was slowly 
poured between the glass plates, up to the required mark. Then 200pl of gel overlay was 
layered over the top and the gel left to set. Once the lower gel was set, the overlay was 
washed off and the 5 % stacking upper gel was poured on. This was prepared by mixing 
together, 5ml upper gel solution, 11.6ml dH2 0 , 3.3ml Acrylamide/Bis. solution, 200pl 
ammonium persulphate and 200pl TEMED. Once the upper gel was poured on, the well- 
comb was inserted and the gel left to set, after which the comb was removed and the 
wells filled with running buffer.
2.12: Renaturable kinase assay.
Freshly isolated PBTLs were isolated and resuspended in 2.5% HSA. 250pl of the cell 
suspension was then aliquoted into each 1.5ml eppendorf tube and incubated at 37°C for 
20 minutes. To each tube 250pl of 2x the final working concentration of the test reagent 
was then added, mixed well and the cells incubated for one hour at 37°C in a water bath. 
After incubation the cells were washed twice in serum free RPMI-1640 media, the 
supernatant aspirated and the cells solubilised in Laemmli sample buffer and boiled for 5 
minutes. Samples were run on 10% (w/v) SDS-PAGE gels according to Laemmli^^®  ^
along with rainbow molecular weight markers (High molecular weight range 14,300- 
220,000 Da, from Amersham,U.K).
The gels were processed for renaturation essentially as described by Kameshita and 
Fujisawa^^^ After washing SDS from the gels (20% isopropanol, 15mM Tris buffer pH
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8.0) and dénaturation for 1 hour in 6M guanidine-HCL, samples were renatured 
overnight at 4°C in 50mM Tris buffer pH 8.0, 50mM 2-mercaptoethanol and 0.04% 
Tween-20. Following equilibration in phosphorylation buffer (lOmM HEPES pH 8.0, 
2mM dithiothreitol, O.lmM EGTA, 5mM MgCl2 (BDH)) the gels were incubated with 
[y^^PJATP (Amersham) (IpCi/ml) for 1 hour at room temperature. Finally, the gels were 
washed extensively with 5% (w/v) trichloroacetic acid containing 1.0% (w/v) sodium 
pyrophosphate and dried. Autophosphorylation was visualised by autoradiography using 
Hyperfilm-MP from Amersham
2.13; Western blotting for tyrosine phosphorylation^^.
Freshly isolated PBTLs were isolated and resuspended in 2.5% HSA. 250pl of the cell 
suspension was then aliquoted into each eppendorf and incubated at 37°C for 20 minutes. 
To each tube 250|il of 2x the final working concentration of the test reagent was then 
added, mixed well and the cells incubated for one hour at 37°C in a water bath. In 
experiments in which the cells were pretreated with herbimycin A, 0.5pl of lO'^M 
herbimycin A was added to the 250pl cell suspension to give a final concentration of 5 x 
lO'^M and the cells incubated for 45 minutes at 37°C, after which the test reagent was 
added as described above. After incubation the cells were washed twice in serum free 
RPMI-1640 media, the supernatant aspirated and the cells solubilised in Laemmli sample 
buffer and boiled for 5 minutes. Samples were run on 10% (w/v) SDS-PAGE gels 
according to LaemmlP^ along with rainbow molecular weight markers (14,300- 
220,000Da, Amersham).
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After electrophoresis, the gels were washed in western blot buffer x3 every 10 minutes 
whilst on a shaker (the BeUy Dancer - Stovall, Life Science Inc, USA.) and then the 
proteins were transferred to nitrocellulose membranes (Hybond™ECL™, Amersham Life 
Science, U.K.) using a Trans-Blot semi-dry transfer cell (BIO-RAD). Nonspecific sites 
were blocked using 5% Bovine serum albumin in PBS/0.1% Tween-20 (PBS/tween) for 
1 hour at room temperature. The membranes were washed 3 times in PBS/tween and 
then the primary antibody - antiphosphotyrosine, (monoclonal IgG2b^ - clone 4G10), 
(Upstate Biotechnology Incorporated, USA) was incubated with the membranes for 1 
hour at a final dilution of 1/2000 in PBS/tween. The membranes were washed 3 times in 
PBS/tween for a period of 1 hour and then incubated with a horseradish peroxidase- 
labeUed sheep anti-mouse IgG (Amersham, U.K.) at a final dilution of 1/2000 in 
PBS/tween. The membranes were washed 3 times in PBS/tween over a period of 1 hour 
and the phosphotyrosine bands were revealed using the ECL detection system 
(Amersham, U.K.) with ECL autoradiography film (Amersham, U.K.).
2.14: Immunofluorescence staining for actin and tubulin in 
PBTLs<^>.
PBTLs were isolated as normal and treated with either lOpM Bis. or 50pM nocadazole 
as described in section 2.14. After which the cells were fixed with 1% para­
formaldehyde. The cells were then permeabilised by incubation at room ten^ierature with 
0.1% lysophosphatidylcholine for 45 minutes on a rotary wheel.. The cells were then 
washed xl in PBS/tween and resuspended in 400pl PBS/tween per treatment. Then 200pl 
from each treatment was put into a separate eppendorf tube. Either of the anti-tubulin 
antibodies was then added to the relevant tubes at a 1 in 1000 dilution (either, mouse
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monoclonal antibody to polymerised p-tubulin, or depolymerised p-tubulin. Both from 
Affiniti Research, Exeter, U.K.). Also the cells were stained for F-actin by the addition 
of rhodamine-labelled phalloidin to a final concentration of 330nM. The cells were then 
left at room temperature for one hour on a rotary wheel (slow speed 25 revs/min.). Cells 
were then washed x3 in PBS/tween and resuspended in 200pl PBS/tween. The secondary 
antibody (anti-mouse polyvalent immunoglobulins - FTTC conjugate) was then added to 
each tube at a 1 in 500 dilution. The cells were incubated at room temperature on a 
rotary wheel for one hour and then washed x4 in PBS/tween and resuspended in Citifluor 
(Citifluor Ltd. London), after which slides were prepared. The cells were viewed using a 
Zeiss Axioscop microscope equipped with epifluorescence and photographs taken using a 
Nikon FX-35DX camera with Ilford PAN F 50 black and white film.
2.15; Measurement of Taurine
MOLT-4 cells were suspended at IxlOVml in 10% FCS media and incubated with 
Taurine [1,2-^^C] (Amersham), O.lpCi/ml for 1.5 hours at 37°C. The cells were then 
washed x2 and resuspended at IxlOVml in 0.5% FCS media. 1ml aliquots were put in 
each eppendorf and the cells incubated at 37°C for 0 (control), 10, 20 or 30 minutes with 
or without 0.5mls dHjO. The cells were then spun down in a microcentrifuge and 500pl 
of the supernatant was collected (control) or 750pl from the hypotonically shocked cells. 
The supernatant was then added to a scintillation vial along with 10ml Ultra gold 
scintillation fluid (Packard, USA), and counted in a Packard 2500 TR liquid scintillation 
analyzer. The cell pellets along with the rest of the supernatant were treated in the same
51
manner. The percentage efflux was calculated as follows [(DPM of supernatant of 
sample x 2) 4- (total DPM of sample)] xlOO.
To test the effects of chloride channel blockers on taurine efflux, the protocol was 
slightly different. The cells were labelled as above and then resuspended at 2xl0^/ml in 
0.5% FCS media. 400|il of the cells were aliquoted into each eppendorf and to this was 
added 400pl of either medium (control) or 2x final concentration of the channel blocker. 
The cells were then incubated 5 minutes on a heating block after which they were 
incubated for a further 20 minutes with or without (control) the addition of 400|il of 
dHjO.
The percentage efflux was then calculated as above.
The chloride channel blockers tested were - NPPB [5-nitro-2-(3’phenylpropylamino) 
benzoic acid], (LC laboratories, Woburn, MA. USA). Tamoxifen [[trans-2-[4- 
(1,2,diphenyl-l-butenyl) phenoxy 1] -N, N-dimethy Icthylaminc] ], (Aldrich-chcmic),
Niflumic acid and Quinidine.
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Chapter 3
The Investigation for inducers of motility
Introduction
Before any investigations into the signal transduction mechanisms involved in PBTL 
motility could be carried out, it was essential to first of all acquire a model in which 
motility could be induced at will so that second messenger involvement could be 
investigated. As well as using fresh human PBTLs, a leukaemia cell line was also used, 
termed MOLT-4 cells. From this cell line, two sublines had previously been isolated, 
termed motile and non-motile (see methods 2 .1).
Both PBTLs and non-motile MOLT-4 cells were used in experiments in which various 
factors were tested for their effect at inducing motility. In initial experiments a simple 
polarisation assay was used in place of a conventional transmigration assay. The degree 
of lymphocyte polarisation or shape change correlates with the degree of motility 
induced^ ^^ ^^  and the assay is a cheaper, better for screening and simpler assay than the 
conventional transmigration assay.
Polarisation assay.
A summary of all the factors tested and their effects can be seen in Table 3.1. All the 
factors tested were chosen because of reported effects on motility in lymphocytes or 
other cell types in the literature. The chemokines M IP-la, MIP-lp, MCP-1 and IL-8 
had minimal effects on PBTLs, causing polarisation to a maximum of 10% of the 
population (all at lO'^M concentration), whereas RANTES had no effect whatsoever in
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this system (all factors tested at concentration range of lO'^^M to lO'^M). The 
chemokines had no polarisation effect at all on the non-motile MOLT-4 cells.
Substance P, vasoactive intestinal peptide (VIP), lysophosphatidic acid (LPA) and 
platelet derived growth factor (PDGF), all caused polarisation in only 10% of the PBTL 
population (all at lO'^M concentration) and had no effects on the non-motile MOLT-4 
cells. IL -la, IL-10, epidermal growth factor and tumour necrosis factor a , all had no 
effects on either PBTLs or non-motile MOLT-4 cells.
Although factors like MCP-1 were found to cause polarisation in 10% of the PBTL 
population, it was decided that this would not provide sufficient sensitivity for 
investigating the second messengers involved. However, 5 factors were found to cause 
significant polarisation in PBTLs and the effects were significant enough to use these 5 
as tools to induce motility in the subsequent investigations into the second messengers 
involved.
Freshly isolated PBTLs are virtually all spherical, non-motile cells as can be seen in 
figure 3.1. The biggest effect was seen with the protein kinase C inhibitor 
bisindolyhnaleimide GF109203X (Bis), which caused up to 60% of the PBTL population 
to polarise (figure 3.2), with a leading edge and a trailing uropod. IL-2, IL-15 and fetal 
calf serum (FCS) also caused the PBTLs to change morphology in the same way as Bis. 
Nocadazole, the microtubule disrupting agent caused shape change in 20 - 30% of 
PBTLs, however, the morphology of the shape change was different from that induced 
by the four other factors in that there was often no typical head or tail structures (fig. 
3.3). Interleukins-2 and -15 were found to cause polarisation in 20 - 30% of the PBTLs 
and FCS caused polarisation in 10 - 20% of the population.
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Only Bis and nocadazole were found to have any effects on the shape of the non-motile 
MOLT-4 cells and because of these limited effects on these cells it was decided to use 
PBTLs as a model for inducing motility successfully.
The dose responses of the polarisation of PBTLs to these 5 inducers of shape change are 
shown below. As can be seen in figure 3.4, the maximum effect of Bis on the 
polarisation of PBTLs was at lOpM concentration, however, above this concentration Bis 
was found to be cytotoxic. Trypan blue tests showed that less than 5% of the PBTLs 
were non-viable after a 1 hour exposure to lOpM Bis. The polarisation effect of the 
microtubule disruptor, nocadazole, on fresh PBTLs is shown in figure 3.5. As can be 
seen from this graph, the optimum concentration for induction of shape change was 
50pM. Above this concentration, nocadazole was found to be slightly toxic, 
nevertheless, trypan blue tests showed that at a 50 pM concentration of nocadazole, less 
than 5% of the PBTLs were non-viable after a 1 hour exposure.
The effects of interleukins-2 and -15 on the polarisation of PBTLs are shown in figure
3.6. As can be seen from these data, IL-15 is almost 10 times as potent as IL-2 at 
inducing shape change in PBTLs. From these experiments it was decided that the 
concentration to use IL-2 as a model for induction of polarisation would be lO'^M and 
IL-15 would be used at a concentration of lO'^M.
Finally, the data for the cell polarisation effects of FCS on PBTLs are shown in figure
3.7. As can be seen from these data the optimum effect was seen with 40% FCS, which 
caused about a 20% increase in PBTL polarisation. However this is a very high FCS
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concentration and would not be practical to use in subsequent experiments as a model. 
Therefore, 20% FCS was chosen as the concentration to be used in subsequent 
experiments, as this still gave an increase of about 15-20%  polarisation.
Transntieration assay.
Although 5 factors were found to induce polarisation in human PBTLs, this was not 
absolute proof that they were causing motility as polarisation of the cell is only the first 
stage of motility. To investigate motility, the transmigration assay was used (see 
methods). In each experiment the PBTLs were incubated for 4 hours in the Costar 
transfilter systems. Also, in concert with each transmigration assay, a polarisation assay 
was carried out on PBTLs from the same donor to assess the polarisation response of the 
cells to the factor being investigated.
Bis. was found to stimulate a significant increase in transmigration of the PBTLs as can 
be seen in figure 3.8. As the concentration of Bis increased so too did the degree of 
transmigration, which correlated with the extent of cell polarisation. This same pattern 
was seen with IL-2 (figure 3.9) and IL-15 (figure 3.10) (this data has been 
publishecP^). However, nocadazole (figure 3.11) and FCS (figure 3.12) failed to cause 
any degree of PBTL transmigration, even though they still caused cell polarisation in 
these cells as normal. Therefore, it can be concluded that nocadazole and FCS do not 
cause actual motility, but they do induce the first stage of motility which is cell 
polarisation and thus they are still useful as tools in this project for investigating the 
second messengers involved in inducing shape change. All transmigration / polarisation
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experiments were done in triplicate with 3 different donors and the results shown in 
figures 3 are representative of 3 experiments.
Videomicroscopy of PBTLs treated with each of the five inducers of shape change, 
confirmed the results of the transmigration assays, in that Bis, IL-2 and IL-15 caused the 
cells to constantly change shape, whereas the FCS or nocadazole treated cells changed 
shape initially but then remained frozen in this shape.
To summarise this stage of the project:- 5 factors were found to cause significant cell 
polarisation in human PBTLs and these were Bis, nocadazole, IL-2, IL-15 and FCS. 
However, only Bis., IL-2 and 11^15 caused transmigration of the cells across 
nitrocellulose filters. Nevertheless, nocadazole and FCS can stiU be used to compare the 
induction of motility (ie: polarisation) with the other three. Using these 5 factors as 
tools, the next step was to analyse the second messengers induced to elucidate if there 
were any common elements, which would then be contenders for part of a final common 
pathway of motility.
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Table 3.1 : Summary of Ivmphocvte polarisation assay results.
Factor tested Non-m. MOLTs PBTLs
GF109203X (Bis.) + + + + + + + + + + + +
Nocadazole + -I- + + + + + +
Interleukin-2 - 4-4-4-
Interleukin-15 - 4-4-4-
Fetal calf serum - 4--H
MIP-1 a - 4-
MIP-IP 4-
RANTES - -
MCP-1 - 4-
Interleukin-8 - 4-
Interleukin-1 a - -
Interleukin-10 N.D -
Substance F - 4-
VIP N.D 4-
LPA N.D 4"
PDGF N.D 4-
EGF N.D -
TNFa N.D -
Ke\ :
+ + + + + + = 50 - 60% of cells shape changed
-H- + + + = 4 0 -5 0 % ..................
+ + + = 20-30% " "
+  +  =  10 - 20%
+  = 0 - 10%
= no effect 
N.D — not done
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Figure 3.1: Freshly isolated Peripheral Blood T Lymphocytes (magnification x630).
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Figure 3.2: PBTLs treated with lOuM Bis, (magnification x630).
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Figure 3.3: PBTLs treated with 50uM Nocodazole.
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Figure 3.4: Dose response of PBTLs polarisation to Bis.
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Figure 3.5: Dose response of PBTLs polarisation to Nocodazole
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Figure 3.6: Dose response of PBTLs polarisation to IL-2 & EL-15.
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Figure 3.7: Dose response of PBTLs polarisation to Fetal calf serum.
w
00
2 0 -
15-
1 0 -
o2
c
U
% PCS
Figure 3.8: The effect of Bis, on the transmigration and polarisation of PBTLs
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Figure 3.9: The effect of IL-2 on the transmigration and polarisation of PBTLs
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Figure 3.10: The effect of IL-15 on the transmigration and polarisation of PBTLs
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Figure 3.11: The effect of Nocodazole on the transmigration and polarisation of
PBTLs
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Figure 3.12: The effect of FCS on the transmigration and polarisation of PBTLs
cu
00
-3V
CÛ
C_ % PBTLs Transmigrated
% PBTLs polarised
% FCS
65
Chapter 4
Investigations into the roles of intracellular calcium and 
phosphoinositides in lymphocyte motility
As mentioned in the introduction section, intracellular calcium ([Ca^^]j) is an important 
regulator in many signal transduction events^^^ \^ however its role in regulation of 
leukocyte locomotion is not yet fully understood^
Intracellular calcium studies.
These experiments were undertaken by labelling freshly isolated human PBTLs with the 
molecular probe FURA-2/AM and upon agonist stimulation, measuring the fluorescence 
via a luminescence spectrometer. Complexing with [Ca^^Jj causes an increased 
fluoresence emission by FURA-2, (see methods).
The aim of this study was to assess whether any of the 5 inducers of shape change would 
affect the [Ca^^], levels. As well as testing these 5, other factors such as the chemokines 
were tested as they have been reported in the literature to affect the [Ca^^], levels in 
monocytes and lymphocytes^^" ’^^ ’^^ "^ .^ The results of these experiments are summarised in 
table 4.1. All experiments in this chapter were done in triplicate unless otherwise stated. 
Also, all experiments with PBTLs were not only done in triplicate, but with 3 different 
donors. As a positive control for the [Ca^^]j measurements, an aliquot of the labelled 
cells were stimulated with lOpM ionomycin (used also as part of the calibration method - 
see methods), which causes an influx of extracellular calcium into the cell (figure 4.1).
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Of the five inducers of polarisation tested, only Bis showed an effect on [Ca^^]; (figure 
4.2). However, the increase in intracellular calcium observed seemed to be a fluorescent 
artifact as the increase was not a typical calcium transient which rises and then
falls back to baseline (as in figure 4.7). As can be seen in fig 4.2, Bis was not 
fluorescing in the abscence of PBTLs. Therefore, a possible answer was that once Bis 
entered the cells it was binding to something intracellularly and this complex was 
autofluorescing and giving a false signal in this system. To determine if this was indeed 
the case, an experiment was carried out whereby, the PBTLs were labelled with FURA- 
2/AM as usual and then before the experiment was run the cells were pretreated with 
0.1% Triton X-100, which is a detergent which permeabilises the cells, thus allowing the 
cells contents to be released into the extracellular media. Then the experiment is run and 
Bis is added to the system. A representative experiment is shown in figure 4.3. As can 
be seen. Bis is causing a response even with the cells pretreated with Triton, which 
proves that Bis is not actually causing an increase in [Ca^^Jj, but is in fact fluorescing 
non-specifically when it is in the presence of intracellular components of the cell.
Three of the chemokines, MIP-la, MIP-ip and MCP-1, seemed to exhibit very small 
effects on the PBTLs [Ca^^], levels, as can be seen in figures 4.4 - 4.6. These small 
effects could be due to the fact that the chemokines are specific for subsets of T cells and 
these experiments contain large populations of all PBTLs. However, some clear results 
were obtained by using non-motile MOLT-4 cells in this system. An example can be 
seen in figure 4.7, in which 10 MCP-1 causes a transient increase in [Ca^^], of about 
200 nM. It must be noted here also that MCP-1 has no polarisation effect at all on the 
non-motile MOLT-4 cells. Similar [Ca^^]j fluxes in non-motile MOLT-4 cells were seen
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with M IP-la, MIP-lp and RANTES, but these results were not as reproducible as the 
MCP-1 effect. These 3 chemokines also had no effect on the polarisation of the MOLT 
cells. Hence, it can be concluded from this data that an increase in [Ca^^], does not seem 
to be essential for the induction of motility in lymphocytes.
Indeed, further experiments provided evidence for the theory that an increase in [Ca^^]j, 
actually prevents the induction of motility. In the first set of these experiments, the 
motile variant of the MOLT-4 cells were used in an experiment in which they were 
exposed to various concentrations of ionomycin, a compound which permeabilises the 
cell membranes and allows an influx of extracellular calcium into the cell. A 
representative experiment can be seen in Figure 4.8. The motile MOLT-4 cells were 
incubated with various concentrations of ionomycin for 30 minutes. As can be clearly 
seen, as the concentration of ionomycin is increased, the cells become less polarised and 
round up. The non-motile MOLT-4 cells were also tested for their response to ionomycin 
exposure. As with the motile variant, the non-motile cells were incubated with various 
concentrations of ionomycin (lO'^M to 10‘^ ^M) for 30 minutes, but no effects on the 
shape of the cells were observed (data not shown), thus indicating that an elevation in 
[Ca^^li is not enough to cause shape change. Ionomycin was also tested to see whether 
after induction of polarisation in PBTLs, ionomycin would reverse the shape change and 
revert the cells back to a spherical, non-motile state. As can be seen in Figure 4.9, this 
was indeed the result. Ionomycin reversed the polarisation induced by each of the five 
factors after 30 minutes. Thus it seemed at this point that by increasing the [Ca^^Jj, this 
in turn prevented motility.
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The endosomal Ca^’*’- ATPase inhibitor, thapsigargin has been reported in the literature 
to increase [Ca^^]j levels in lymphocytes^Thapsigargin was then tested to see if it, 
like ionomycin reduced the extent of polarisation in motile MOLT-4 cells and prevented 
the polarisation induced in PBTLs. Thapsigargin was found to have no effect on the 
polarisation of motile MOLT-4 cells and no effect on their [Ca^^]j levels (data not 
shown). In experiments in which PBTLs were pretreated with thapsigargin for 15 
minutes and then stimulated with either of the five inducers of shape change for a further 
45 minutes, it was observed that thapsigargin significantly prevented the induction of 
polarisation in these cells (figure 4.10). To prove that thapsigargin does indeed cause an 
increase in [Ca^^]j levels in PBTLs, experiments with FURA-2 labelled PBTLs were 
carried out in which they were stimulated with lOuM thapsigargin. A representative 
experiment can be seen in figure 4.11, in which thapsigargin induces a [Ca^^], increase 
of about 135nM . However when the cells are exposed to 5mM EOT A for 5 minutes 
before the experiment is started there is no increase in [Ca^^Jj, upon thapsigargin 
stimulation. This shows that the majority of the increase in [Ca^^j; is not from the release 
of Ca^’*’ from intracellular stores but a concomitant influx of Ca^^ from the extracellular 
medium due to increases in plasma membrane Ca^^ permeability. It is thought that a 
second messenger known as Ca^^ influx factor (GIF) is released or generated from the 
endoplasmic reticulum or adjacent regions once the [Ca^^jj concentration in this 
organelle falls beneath a critical level^^^ \^ Further evidence to support the notion that an 
increase in [Ca^^jj, actually prevents the induction of motility is shown in figure 4.12. 
Again PBTLs that are pretreated with thapsigargin are unable to polarise upon 
stimulation with the 5 inducers of shape change. However when the same experiment is 
done again but the cells are pretreated with 5mM EGTA (to chelate the extracellular
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Ca^^) before treatment with thapsigargin, then the PBTLs are able to polarise as normal, 
thus indicating that the increase in [Ca^^]j induced by thapsigargin is of extracellular 
origin.
Phosphoinositide studies.
In recent years phosphoinositides have been shown to play a key role in signal 
transduction^^^ '^^^^\ As mentioned in the introduction section, there are links between 
alterations in polyphosphoinositides (ppl’s) and changes in [Ca^^], levels. Stimulation of 
cell surface receptors initiates hydrolysis of a membrane-bound inositol lipid, which 
produces at least two second messengers, - diacylglycerol (DAG) and inositol 1,4,5- 
triphosphate (IP3). These messengers are generated by a membrane transduction process 
comprising 3 main components: a receptor, a coupling G protein and phosphoinositidase 
C. DAG acts by stimulating PKC whereas IP3 releases calcium from internal stores.
The first investigation into the role of ppl’s in the induction of motility was by assaying 
IP3 production in PBTLs upon stimulation with inducers of shape change. This work was 
done using the IP3 assay kit from Amersham (see methods). A representative experiment 
can be seen in figure 4.13. It is clear from this data that there are no significant changes 
in IP3 levels detected with this methodology when the PBTLs are stimulated by the 
inducers of shape change. In these experiments the cells were stimulated with the 
agonists for a standard time of one minute. From this data it seeems that IP3 is not 
involved in a motility signal transduction pathway.
The involvement of the phosphoinositide 3-kinase (PI 3-kinase) in the induction of 
motility was investigated by using specific inhibitors of the kinase. A fungal metabolite
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known as wortmannin has proved to be a selective inhibitor of PI 3-kinase, if used at 
sub-lOOnM concentration^PB TLs were preincubated with various concentrations of 
wortmannin for 30 minutes and then stimulated with the 5 inducers of polarisation for 1 
hour. A representative experiment can be seen in figure 4.14. Wortmannin has 
prevented polarisation of the PBTLs but only at concentrations above lOOnM. It must be 
noted at this point that wortmannin has an IC5 0  ~3nM, therefore at concentrations above 
lOOnM, wortmannin is no longer specific for PI 3-kinase and affects other systems such 
as phospholipase D, myosin light chain kinase and pleckstrin. Wortmannin was found to 
have no effect at all on the motile MOLT-4 cells (data not shown).
Another specific PI 3-kinase inhibitor is a compound known as LY294002^^ '^^\ which 
inhibits PI 3-kinase activity with an IC5 0  of 1.4pM. This compound was also tested to see 
whether it would prevent the induction of polarisation in PBTLs. PBTLs were 
preincubated for 15 minutes in the presence of various concentrations of LY294002 and 
then stimulated with the 5 inducers of polarisation for 1 hour. A representative 
experiment can be seen in figure 4.15. The inhibitor was found to significantly inhibit 
the induction of polarisation by all five inducers at concentrations as low as lOOnM. 
Therefore these data suggest that PI 3-kinase may be involved in a motility pathway. 
However, the LY294002 compound was found to have no effect whatsoever on the 
polarisation of the motile MOLT-4 cells (data not shown). This seems to be a conflicting 
result to the experiments with wortmannin, however the fact is that wortmannin is less 
stable than LY294002 and this could explain why wortmannin did not inhibit motility.
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When administered to animals, lithium induces subtle alterations in neural activity (for 
example in manic-depressive illness and diurnal rhythms) and early development 
(teratogenesis). Lithium is known to reduce the supply of inositol, the key substrate for 
the phosphoinositide cascade by inhibiting some of the enzymes which hydrolyse the 
inositol phosphates^^^^\ Thus lithium inhibits signal transduction indirectly by slowing 
down the supply of the precursor lipid required to generate messengers such as IP3 and 
DAG.
Therefore, as an additional approach to investigate the involvement of phosphoinositides 
in motility, lithium chloride was tested for effects on the polarisation of PBTLs and 
MOLT-4 cells. In figure 4.16 is a representative experiment in which PBTLs were 
preincubated with lithium chloride for 30 minutes prior to stimulation with the various 
inducers of polarisation for 1 hour. A concentration of lOOmM lithium was found to 
inhibit polarisation by all five agonists, however at lower concentrations only the effects 
of IL-2, IL-15 and FCS were blocked. Lithium chloride was found to have no effect 
whatsoever on the polarisation of the motile variant of the MOLT-4 cells. Reports in the 
literature suggest a concentration of lOmM for 30 minutes is sufficient to disrupt the 
phosphoinositide cascade  ^181 ,1 9 9 )
To summarise this chapter; it was found that an increase in [Ca^^Jj was not essential for 
the cells to polarise, in actual fact it was found that an increase in [Ca^^], levels 
inhibited polarisation. PBTLs polarisation did not increase intracellular IP3 levels and the 
role of PI 3-kinase in the signal transduction of motility was uncertain as one PI 3-kinase
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inhibitor (wortmannin) did not inhibit motility, whilst another PI 3-kinase inhibitor 
(LY294002) did.
However, experiments with lithium suggest that ppis may be involved in motility, as it 
prevented polarisation by all five shape change inducers. It seems that the ppl’s are more 
important for the signal transduction events utilised by IL-2, IL-15 and FCS. The results 
obtained with the MOLT-4 cells did not always back up those of the PBTLs, but these 
are transformed cells and they are already motile, therefore it would be expected that 
compounds which inhibit the induction of motility, would have no effect.
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Table 4.1: Summary of intracellular calcium studies on PBTLs^
---------------------------------------------
Factor Tested Increase in [Ca^^jj (nM) % Cells polarised
Bis. (GF109203X) (lOfM) 0 (autofluorescence) Î  50 - 60%
Interleukin-2 (10'^M) 0 Î  20 - 30%
Interleukin-15 (10'^M) 0 T20-30%
Nocodazole (50juM) 0 T 20  - 30%
Fetal calf serum (107o) 0 T 10 - 2 0 %
MIP-la (Iff^M) 0 -1 0 T 10 - 2 0 %
MIP-1J3 (la^M) 0 -1 0 t o  - 10%
MCP-1 (lO'^M) 0 -1 0 t  0 - 10%
lnterleukin-8 (10'^ to lO'^M) 0 0
RANTES (la^tolO'^M) 0 0
Figure 4.1: The effect of 10uM Ionomycin on PBTLs FCa—L levels
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2+-Figure 4.2: The effect of Bis, on PBTLs [Ca—^ levels
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Figure 4.3: The effect of Bis, on PBTLs ICa—L levels, + /- pretreatment with Triton 
X-100
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Figure 4.4: The effect of M IP -la  on PBTLs FCa—1, levels
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Figure 4.5: The effect of MIP-IB on PBTLs FCa—L levels
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Figure 4.6: The effect of MCP-1 on PBTLs rCa—IJevels
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Figure 4.7: The effect of MCP-1 on non-motile MOLT-4 cells FCa—L levels
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Figure 4.8: The effect of Ionomycin on the polarisation of motile MOLT-4 cells
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Figure 4.9: The effect of Ionomycin on the polarisation of PBTLs
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Figure 4.10: The effect of thapsigargin on the polarisation of PBTLs
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Figure 4.11: The effect of thapsigargin on the FCa—]; levels of PBTLs
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Figure 4.12: The effect of thapsigargin on the polarisation of PBTLs pretreated 
with 5mM EGTA
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Figure 4.13: Assay of IP, production in PBTLs upon polarisation
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Figure 4.14: The effect of wortmannin pre-treatment on induction of polarisation in 
PBTLS
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Figure 4.15: The effect of LY294002 pre-treatment on the induction of polarisation
in PBTLs
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Figure 4.16: The effect of lithium chloride pre-treatment on the induction of
polarisation in PBTLs
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Chapter 5
Investigations into the roles of intracellular pH and ion 
channels in lymphocyte motility
Introduction.
Maintenance of intracellular pH within eukaryotic cells is dependent on the
concerted action of a number of specific transporters and ion channels^ Together 
these proteins act to regulate pHj to specific and characteristic values for a given cell 
type^^^ \^ The need to control intracellular pH reflects the exquisite pH sensitivity of 
many biological processes, such as protein synthesis, ion conductivities and DNA 
rep lication^R ecent studies have also suggested that many cellular activation processes 
mediated by growth factors and other exogenous stimuli involve changes of pH, as part 
of the activation process^^^^^^ \^ Neutrophils, for example, change their intracellular pH 
after they encounter chemotactic f a c t o r s ^ W h e n  this pH change is prevented 
pharmacologically, neutrophils do not respond to the chemotactic agent, indicating the 
importance of this ionic alteration^
The major components of the pH regulatory apparatus involve both sodium-dependent 
and sodium-independent processes. The Na"^/H^ antiporter is a ubiquitous transporter 
involved in pH homeostasis, sodium concentration and regulation of cell volume^ 
Activity of this transporter is affected by various effector molecules, including serum 
factors^^^ ’^^ ^^  ^ and is inhibited selectively by certain amiloride derivatives^^^^\ In addition
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to the Na^/H"^ antiporter, both sodium-dependent and sodium-independent bicarbonate 
exchangers have been identified as participants in pH homeostasis^
Intracellular pH measurements
In view of the importance of pH in the regulation of cellular activities, agents that alter 
pHj would be expected to influence a number of cell functions. Therefore, it was 
investigated, if by inducing motility in PBTLs, this would then affect the pH,. These 
experiments were carried out by labelling fresh PBTLs with BCECF/AM and then 
measuring the fluorescence emitted upon agonist stimulation in a luminescence 
spectrometer (see methods). All five inducers of polarisation were tested in this system. 
None of these showed any effects whatsoever on the pHj of PBTLs or non-motile 
MOLT-4 cells. A representative result is shown in figure 5.1, in which PBTLs were 
stimulated with lOpM Bis. The positive control for these experiments was 40mM sodium 
propionate (figure 5.2). Within each experiment, an aliquot of the BCECF labelled cells 
was tested with 40mM sodium propionate as a positive control. Weak organic acids such 
as sodium propionate lower pHj within eucaryotic cells by their passive diffusion as free 
acids across the plasma membrane and their subsequent dissociation within the 
cytosol^^^^\ The ability of mammalian cells to recover from this acute acid load is the 
result of the Na^/H^ exchange/
Role o f ion channels in motility
There is evidence in the literature which suggests that the Na^/H^ exchanger has an 
important role to play in the locomotion of neutrophils^ Therefore it was investigated 
by using specific inhibitors of the Na^/H^ antiporter, whether these would inhibit
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motility in lymphocytes. The inhibitors used were amiloride and its de r i va t i ves^The  
effect of these Na"""/H  ^ antiporter inhibitors on the polarisation of motile MOLT-4 cells 
is shown in figure 5.3. The most potent compounds were amiloride 5-(N,N- 
hexamethylane) (A130), amiloride 5-(N-methyl-N-isobutyl) (A149) and amiloride 5-(N- 
ethyl-N-isopropyl) (A171), which virtually rounded up all the cells at lOOpM. The other 
two inhibitors, amiloride 5-(N,N-dimethyl)-hydrochloride (A 125) and amiloride 
hydrochloride (A ll3) were less potent as they only had effects at 500pM and above. In 
these experiments, the cells were incubated with the inhibitors for a period of 1 hour. All 
experiments in this chapter were done in triplicate and all experiments with PBTLs were 
also done with 3 different donors, unless otherwise stated. In figures 5.4 - 5.8 are 
representative results of experiments in which PBTLs were pre-incubated with the 
particular amiloride derivative for 30 minutes and then the PBTLs were incubated with 
an inducer of shape change for 1 hour. A130 (fig. 5.4), A149 (fig. 5.5) and A171 (fig. 
5.6), all inhibited polarisation of the PBTLs at a concentration of lOOpM. A125 
inhibited shape change at a higher concentration of 500uM (fig. 5.7) and A113 was the 
least potent as it inhibited shape change significantly at a concentration of ImM (fig. 
5.8).
To prove that the amiloride compounds were indeed preventing motility by inhibiting the 
action of the Na'^/H^ antiporter, it was investigated whether the amilorides would 
decrease the pHj of motile MOLT-4 cells. In theory, if the amilorides were indeed 
blocking the antiports, this would lead to a build up of ions within the cell and a 
decrease in pHj. A representative experiment can be seen in figure 5.9, in which BCECF 
labelled motile MOLT-4 cells were stimulated with lOOpM A130 after 60 seconds.
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Although there is an increase in fluorescence upon stimulation with A130, there is also 
an increase in the negative control (ie: in the presence of no cells). This autofluorescence 
was seen with all the amiloride derivatives. Attempts at the same experiment were made 
using an alternative pHj probe termed SNARF-1 which works at different wavelengths to 
BCECF. Although the amilorides were found not to autofluoresce at the wavelengths 
used by SNARF-1 , this probe was found not to be sensitive enough to pick up any 
changes in pHj (data not shown).
Therefore it could not be proved directly that the amilorides were blocking the antiports. 
However an indirect way of investigating whether the antiport is being blocked is by 
testing the ability of the cells to recover from an acute acid load. In figure 5.10 can be 
seen a representative experiment in which control motile MOLT-4 cells were subjected to 
a 40mM dose of sodium propionate which caused an acute drop in pHj which then 
returned to normal over time due to the activity of the Na^/H^ antiporter which pumps 
out the ions. However, MOLT-4 cells which have previously been treated for 5 
minutes with lOOpM A171, have their recovery from the sodium propionate load 
impaired resulting in a sustained acidification, suggesting that the antiporters have been 
blocked. However, it must be noted at this point that these experiments were very 
difficult to do and the result shown in fig. 5.10 is not very convincing, but there is a 
better example of this type of experiment in fig. 5.19.
A question which arises from this data is whether the decrease in pHj caused by 
inhibition of the antiporter is the reason that amiloride is blocking polarisation of the 
cells. Thus, an experiment was set up whereby motile MOLT-4 cells were exposed to 
various concentrations of sodium propionate and the resulting pHj measured and extent
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of cell polarisation quantified. As can be seen in figure 5.11, as the concentration of 
sodium propionate increases from ImM, at which there is no effect, to 40mM, the extent 
of intracellular acidification increases. In figure 5.12 is a representative experiment in 
which motile MOLT-4 cells are subjected to various doses of sodium propionate for 5, 
15 and 30 minutes. A dose of ImM has little effect on cell polarisation as on pH,, but a 
concentration of 20mM causes the cells to round up and to a further extent with 40mM. 
This pattern correlates with the effects on pHj. It does seem however that the effects are 
transient, with a more pronounced effect after 5 minutes but after 30 minutes exposure to 
sodium propionate there is no effect on the cells polarisation, which is probably due to 
the cells recovery from the acidification. This data suggests that it is the intracellular 
acidification which is responsible for making the cells non motile.
Is there a difference in the pH, levels between motile and non motile MOLT-4 cells?
Also is there a difference in their ability to recover from an acute acid load? To answer 
these questions a number of experiments were carried out whereby both motile and non- 
motile MOLT-4 cells were subjected to 40mM sodium propionate and then the recovery 
to basal pH; was measured over a 30 minute period. A representative result is shown in 
figure 5.13. In this experiment there is a difference in basal levels of pH,, between the 
two cell types, however this varied from one experiment to another, with the motile cells 
exhibiting a higher pHj in one experiment and the non-motiles exhibiting a higher one in 
another, therefore, very little can be read into this. Also, both types of MOLT-4 cells 
were identical in their ability to recover from an acute intracellular acidification. Hence, 
it can be concluded that pHj, is not an important difference between motile and non- 
motile MOLT-4 cells.
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As well as the amiloride compounds, a number of propietary compounds were tested 
which are more potent than commercially available amiloride derivatives and with ICgo’s 
for antiport inhibition of sub-pM concentrations in other experimental systems (N. 
Matthews, personal communication). These inhibitors were termed inhibitor 1 , inhibitor 
2, etc.. As in the previous experiment with the amiloride derivatives, the inhibitors were 
incubated at 37°C with motile MOLT-4 cells for a period of 1 hour. A representative 
experimental result can be seen in figure 5.14. As can be clearly seen, only inhibitor 3 
had any effect on the motile MOLT-4 cells polarisation, rounding up all the cells at 
lOOpM. The antiport inhibitors were then investigated in experiments with PBTLs, to see 
if they could block the induction of shape change. PBTLs were incubated for 30 minutes 
with the inhibitor being tested and then the PBTLs were stimulated by one of the 
inducers of polarisation for 1 hour. Inhibitor 1 had some effects at reducing the extent of 
polarisation (figure 5.15). Inhibitor 2 had no effect whatsoever (data not shown). 
Inhibitor 3 was found to be the most effective of the six inhibitors, as it nearly blocked 
the effects of the inducers of polarisation at a concentration of lOOpM (figure 5.16). 
Inhibitor 4 was slightly more potent than inhibitor 1 (figure 5.17) and inhibitor 5 had a 
slight effect at lOOpM concentration (figure 5.18). Inhibitor 6  had no effect at all (data 
not shown).
From this data, inhibitor 3 proved to be the most potent compound and as with the 
amiloride A171, it was investigated whether inhibitor 3 was actually blocking the 
antiporter, by testing the ability of inhibitor 3 treated motile MOLT-4 cells to recover 
from an acute acid load. A representative experiment is shown in figure 5.19, in which 
the control cells (not treated with an antiporter inhibitor) recover from the acid load as
8 8
normal. However motile MOLT-4 cells that were treated with lOOpM inhibitor 3 for 5 
minutes prior to the start of the experiment, were unable to recover from the acid load as 
quickly as control cells, thus indicating that the inhibitor 3 is indeed targeting the 
antiporter.
To summarise, this data indicates that the induction of polarisation in MOLT-4 cells and 
PBTLs does not affect the pH; of the cells, however upon intracellular acidification, 
motile MOLT-4 cells lose their polarity. Using inhibitors, it was found that inhibition of 
the antiports, which in turn caused intracellular acidification, prevented the cells from 
polarising.
Chloride channels
Research in the past has shown that chloride movements, which occur via Cl’ channels or 
a Cr transporter, have many physiological roles in various cells, such as pH 
control^^°^’^ °^  ^ and cell volume control^ °^^ '^ ^^ '^ "^^ \ Also it has been found that upon agonist 
stimulation, there is a Cl’ efflux from human neutrophils^^°^\
It was therefore decided, to investigate the role if any of Cl channels in lymphocyte 
motility. A number of Cl channel blockers were used in polarisation assays to assess 
whether they could block or reverse shape change. In figure 5.20 is a representative 
experiment in which motile MOLT-4 cells were incubated for 1 hour with one of 3 
inhibitors, quinidine, niflumic acid or 5-nitro-2 [3'-phenyIpropylamino]benzoic acid 
(NPPB). As can be seen, NPPB was the most effective as it virtually rounded up all the 
cells at lOOpM. At the same concentration niflumic acid and quinidine only rounded up
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half the cells. Tamoxifen (trans-) which as well as being an anti-oestrogen, is a chloride 
channel blocker and significantly inhibited motile MOLT-4 polarisation as can be seen in 
figure 5.21. At a concentration of 12.5pM, tamoxifen inhibited all polarisation of the 
motile MOLT-4 cells. Tamoxifen had the same potency at blocking induction of 
polarisation in PBTLs, as can be seen in figure 5.22. This is a representative experiment 
in which tamoxifen was incubated with the PBTLs for 15 minutes and then the cells were 
stimulated with one of the five inducers of polarisation for 1 hour. Using this same 
experimental protocol, the other Cl channel inhibitors were tested for their ability to 
block polarisation in PBTLs. NPPB was effective at a concentration of lOOpM (figure 
5.23), whereas quinidine (figure 5.24) and niflumic acid (figure 5.25) were less 
effective, both only blocking the extent of polarisation by about 25%, at a lOOpM 
concentration.
To determine if these chloride channel blockers were indeed targeting the chloride 
channels, a number of experiments were done whereby MOLT-4 cells were labelled with 
‘^^ C Taurine (see methods). It has been validated in the literature that the physiological 
role of volume regulated chloride channels relates not only to their permeability to the 
inorganic Cl’ but to their permeability to larger organic osmolytes such as taurine^^^ ’^^ ^^  ^
and so therefore the measurement of taurine efflux from hypotonically shocked, taurine 
labelled cells is an indicator of volume regulated chloride channel activity. In figure 
5.26 is a representative experiment in which both motile and non-motile MOLT-4 cells 
were compared in terms of taurine efflux after hypotonic shock. As can be seen from this 
data, taurine uptake by both types of cells were roughly the same and upon hypotonic 
shock to increase the cell volume, the volume regulated chloride channels are activated
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in both cell types. Also the volume regulated chloride channel (as measured by taurine 
efflux) does not appear to be spontaneously activated in motile MOLT-4 cells. Upon 
hypotonic shock, the amount of taurine released did not differ that much between 10 
minutes and 30 minutes in the presence of water. In figure 5.27, is a representative 
experiment, whereby motile MOLT-4 cells were treated with one of the Cf channel 
blockers for 5 minutes and then the cells were hypotonically shocked to test whether the 
blocker could indeed block the taurine efflux. In these experiments the cells were 
hypotonically shocked for 20 minutes. As can be seen from fig. 5.27, the control cells 
all released a small amount of taurine, however it was observed that tamoxifen (12.5pM) 
seemed to cause some spontaneous activation (or toxicity) of the channels as even 
without hypotonic shock the tamoxifen treated cells were releasing more taurine than 
control cells. Upon hypotonic shock, the only compound which seemed to have any 
effect was NPPB which blocked half of the taurine efflux. Niflumic acid and Quinidine 
had no effect on blocking the taurine efflux and tamoxifen actually caused more taurine 
efflux than control cells. The concentrations of the blockers used in these experiments 
was the concentration that gave maximum inhibition of motility in motile MOLT-4 cells 
(figures 5.20 and 5.21).
Therefore, this data suggests that blocking the volume regulated chloride channels does 
not seem to be the mechanism by which these compounds (except tamoxifen) inhibit 
motility and they must be targetting other elements of the cell machinary.
It was also found that none of the Cf channel blockers had any effect on the pHj of either 
PBTLs or motile MOLT-4 cells (data not shown). Hence, these data suggest that the Cl
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channel blockers can inhibit lymphocyte motility by a mechanism independent of pH 
regulation.
Figure 5.1: The effect of Bis on the pH; of PBTLs
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Figure 5.2: The effect of sodium propionate on dH, of PBTT.s
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Figure 5.3: The effect of amilorides on the polarisation of motile MOLT-4 cells
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Figure 5.4: The effect of amiloride A130 on the induction of polarisation in PBTT s
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Figure 5.5: The effect of amiloride A149 on the induction of polarisation in PBTLs
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Figure 5.6: The effect of amiloride A171 on the induction of polarisation in PBTLs
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Figure 5.7: The effect of amiloride A125 on the induction of polarisation in PBTLs
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Figure 5.8: The effect of amiloride A113 on the induction of polarisation in PBTLs
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Figure 5.9: The effect of amiloride A130 on the pH; of motile MOLT-4 cells
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Figure 5.10: The effect of A171 on the ability of motile MOLT-4 cells to recover 
from an acute acid load
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Figure 5.11: The effect of sodium propionate on the pH; of motile MOLT-4 cells
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Fkure 5.12: The effect of sodium propionate on the polarisation of motile MOLT-4
cells
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Figure 5.13: Comparison between motile and non-motile MOLT-4 cells in their 
ability to recover from an acute acid load
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Figure 5.14: The effect of Na~/H— antioort inhibitors on the polarisation of motile
MOLT-4 cells
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Figure 5.15: The effect of antioort inhibitor-1 on the induction of polarisation in 
PBTLs
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Figure 5.16: The effect of antioort inhibitor-3 on the induction of polarisation in
PBTLs
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Figure 5.17: The effect of antiport inhibitor-4 on the induction of polarisation in
PBTLs
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Figure 5,18: The effect of antiport inhibitor-5 on the induction of polarisation in
PBTLs
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Figure 5.19: The effect of antioort inhibitor-3 on the ability of motile MOLT-4 cells 
to recover from an acute acid load
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Figure 5.20: The effect of Cl~ channel inhibitors on the polarisation of motile
MOLT-4 cells
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Figure 5.21: The effect of tamoxifen on the polarisation of motile MOLT-4 cells
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Figure 5.22: The effect of tamoxifen on the induction of polarisation in PBTLs
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Figure 5.23: The effect of NPPB on the induction of polarisation in PBTLs
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Figure 5.24: The effect of quinidine on the induction of polarisation in PBTLs
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Figure 5.25: The effect of niflumic acid on the induction of polarisation in PBTLs
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Figure 5.26: Comparison of Taurine efflux from motile and non-motile MOLT-4
cells.
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Figure 5.27: Do the Cl'channel blockers block volume regulated chloride channels in 
motile MOLT-4 cells as assayed by Taurine efflux.
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Chapter 6
Investigations into the roles of renaturahle kinases in
lymphocyte motility
Introduction
In 1989, Ferrell and Martin™, utilized a method to search for novel protein kinases in 
platelets that involved subjecting lysates to SDS-PAGE, transferring the proteins to 
nitrocellulose and renaturing the blotted enzymes. The protein kinases were detected by 
autoradiography after autophosphorylation with [y^^PjATP. These renaturation kinase 
assays have since demonstrated the activation of multiple protein kinases in a variety of 
cell types, including chemoattractant treated neutrophils^^®^™ and chronic treatment of 
large granular lymphocytes and T cells with okadaic acid^^ ’®\
Renaturable kinase assay
A modified version of the method above (see methods) was used to determine if there 
was any activation of renaturable protein kinases upon induction of polarisation in freshly 
isolated human PBTLs. PBTLs were treated for 1 hour at 37°C, with an inducer of 
polarisation, then lysed and the proteins separated by SDS-PAGE. The gel was then 
renatured as described in methods section and the activities of autophosphorylated protein 
kinases were located by autoradiography after exposure to [y^^PjATP. It must be noted 
at this point that with every experiment, an aliquot of the treated PBTLs was fixed and 
scored for the extent of polarisation induced. In the results shown, the inducers of
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polarisation were found to induce shape change to the expected degree as shown in 
chapter 1.
The results shown in figures 6.1 and 6.2 are representative of 4 experiments, all done 
with different PBTL donors. In figure 6.1, the most prominent event is the Bis induced 
increase in autophosphorylation of a 58kDa band (indicated by the arrow). This same 
band was induced in all four experiments by Bis. Also in figure 6.1, there is a significant 
increase in autophosphorylation of a doublet (indicated by the arrows), of 98 and 92kDa 
by lL-2, lL-15 and nocadazole. This same doublet seems to be increased also in figure 
6.2 by lL-2, Bis and PCS, however these were not found to be reproducible in further 
experiments.
Collaborative work with C.Southern in this Institute has shown that activation of the 
58kDa kinase by Bis occurs after 1 minute and increases up to a maximum level after 30 
minutes. This time scale also correlates with the degree of polarisation of non motile 
MOLT-4 cells induced by Bis. In the case of the 58kDa band, phosphoamino acid 
analysis revealed autophosphorylation on threonine residues and recent work has 
identified the 58kDa kinase as being mammalian ste20-like kinase-1 (MST-1) (personal 
communication, C.Southern).
Hence, there is some evidence to suggest that this 58kDa kinase (MST-1) may be 
involved in a motility pathway, however, it is not conclusive as lL-15, lL-2, PCS and 
nocadazole do not seem to affect the kinase as Bis does.
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Figure 6.1: The effect of induction of polarisation in PBTLs on renaturable kinases 
autophosphorvlation
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Figure 6.2: The effect of induction of polarisation in PBTLs on renaturable kinases 
autophosphorvlation
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(approximate molecular weights kDa o f the protein bands are indicated on the left o f the pictures)
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Chapter 7
Investigations into the roles of tyrosine phosphorylation 
in lymphocyte motility
Introduction
Tyrosine phosphorylation is now recognised as a key mechanism by which cytokine 
receptors and antigen receptors of lymphocytes initiate intracellular events^^^^\ also, the 
phosphorylation of signalling proteins on tyrosine is essential for cellular regulation of 
growth and differentiation.
Tyrosine phosphorylation studies
These experiments were undertaken (as detailed in methods section) by incubating 
freshly isolated human PBTLs with one of the five inducers of polarisation at 37°C for 
one hour. Then the cells were lysed and the proteins separated by SDS-PAGE, after 
which the gels were subjected to Western blotting with the nitrocellulose blots being 
probed for phosphotyrosine. With each experiment, an aliquot of the treated cells was 
checked for extent of polarisation induced. In all experiments shown, there was a normal 
degree of polarisation induced as shown in chapter 1.
As can be seen in figure 7.1 (representative of 3 experiments with 3 different donors) , 
only IL-2 caused any change in tyrosine phosphorylation levels in whole cell lysates of 
treated PBTLs. There is a significant increase in tyrosine phosphorylation of a protein 
band of 'llOkDa molecular weight (indicated by the arrow). There is unequal loading
109
of protein in the FCS treated lane, however other experiments showed FCS to have no 
effect on tyrosine phosphorylation levels (data not shown). Later experiments with IL-15 
showed it to have the same effect as IL-2, (figure 7.2), (representative of 3 experiments 
with 3 different donors), in that it also caused tyrosine phosphorylation of a protein band 
of 'llOkDa. To further test the involvement of tyrosine phosphorylation in lymphocyte 
motility, experiments were carried out in which established tyrosine kinase inhibitors 
were incubated with the PBTLs prior to them being induced to polarise by Bis, etc.
Genistein, tyrphostin A25 and tyrphostin A47, were all tested for inhibiting induction of 
polarisation in PBTLs by all five inducers of polarisation, by incubating the cells with 
the relevant inhibitor for 30 mins at 37°C and then stimulating the cells with one of the 
inducers of polarisation for one hour at 37°C. The inhibitors were tested at 
concentrations from lOOnM to ImM and all experiments were done in triplicate with 
cells from 3 different donors. None of these inhibitors had any effect at preventing the 
extent of polarisation induced (data not shown). However, similar experiments with the 
tyrosine kinase inhibitor herbimycin A (IC5 0  = lp,M), proved otherwise (figure 7.3). 
PBTLs were incubated with 5x10’^  herbimycin A for 30 minutes (as done previously by 
P.C.Wilkinson^^^^) and then stimulated with the inducers of polarisation for 1 hour at 
37°C. As can be seen from figure 7.3, herbimycin A has significantly reduced the extent 
of polarisation induced by Bis, nocadazole, IL-2, IL-15 and FCS. The experimental data 
shown is representative of 3 experiments done with 3 different blood donors.
Thus, this data suggests that there is something common between the 5 different 
treatments that induces polarisation, that is in turn inhibited by herbimycin A.
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The next obvious experiment to do was to investigate whether IL-2 and IL-15 could still 
cause tyrosine phosphorylation of the llOkDa protein if the cells were pretreated with 
herbimycin A (thus reducing the extent of motility). Representative results of these 
experiments are shown in figures 7.4 and 7.5. The experiments as usual were done 3 
times with different blood donors. The cells were treated as in figure 7.3. As can be 
seen in figure 7.4, herbimycin A has not prevented the tyrosine phosphorylation of the 
llOkDa band by IL-2 or IL-15 as can be seen in figure 7.5. This data suggests that 
herbimycin A is not preventing the llOkDa protein (pi 10) from being tyrosine 
phosphorylated, so therefore herbimycin A must be inhibiting its target downstream from 
the pi 10. This theory does not rule out the possibility that the pi 10 might be part of a 
motility signal transduction pathway, common to both IL-2 and IL-15.
So what is the identity of the pi 10? Evidence from the literature suggests the closest 
possibility is Janus kinase-3^ ^^ '^^ '^^  ^ (JAK-3), which has a molecular weight of ~120kDa. 
However, attempts to immunoprecipitate JAK-3 from PBTL cytoplasmic fractions with 
anti-JAK-3 antibodies (see methods), proved unsuccessful (data not shown).
To summarise this chapter, no common changes in tyrosine phosphorylation levels of 
PBTLs, were found to be induced by the 5 inducers of polarisation. However, IL-2 and 
IL-15 were found to both cause an increase in tyrosine phosphorylation of pi 10, which 
could be JAK-3. The tyrosine kinase inhibitor, herbimycin A was found to significantly 
reduce the extent of polarisation induced by all five of the inducers, but it did not affect 
the tyrosine phosphorylation of pi 10 by IL-2 and IL-15.
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Figure 7.1: The effect of induction of polarisation in PBTLs on tyrosine
phosphorylation in PBTLs
A =  EGF receptor (positive control) 
B =  Control (no agonists)
C =  20%  FCS
D =  HUVEC conditioned media 
E =  IO ’m  IL-2 
F =  lOfxM Bis 
G =  50fxM nocadazole
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Figure 7.2: The effects of IL-2 and IL-15 on tyrosine phosphorylation in PBTLs
A =  Control (no agonists) 
B =  lO '^M IL-2 
C =  10 ® M IL-15 
D -  Control (no agonists) 
E =  IO ’ m  IL-2 
F =  10* M IL-15
E D C 8
-2 2 0
■ -9 7 4
(approximate molecular weights kDa of the protein bands are indicated on the right o f the pictures)
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Figure 7.3: The effect of herbimycin A pre-treatment on induction of polarisation in
PBTLs
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Figure 7.4: The effect of herbimycin A pre-treatment on tyrosine phosphorylation
induced by IL-2 in PBTLs.
A =  Control 
B =  10'’ M IL-2 
C =  5x10'^ M herbimycin A 
D =  5x10'^ M herbimycin A 
and 10 IL-2
D B
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Figure 7.5: The effect of herbimycin A pre-treatment on tyrosine phosphorylation 
induced by IL-2 and IL-15 in PBTLs
A =  Control (no agonists)
B =  IO ’ m  IL-2 
C =  10 ® M IL-15 
D =  5x10'^ M Herbimycin A  
E =  5x10'^ M Herbimycin A & lO'^M IL-2 
F =  5x10^ M Herbimycin A & 10‘*M IL-15 
G =  5x10'^ M Herbimycin A 
H =  5x10 ’^  M Herbimycin A & lO’^ M IL-2 
I =  5x10  ^M Herbimycin A & 10 ®M IL-15
I H
S5a*“
- 2 2 0
-97 .4
(approximate molecular weights kDa of the protein bands are indicated on the right of the pictures)
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Chapter 8
Investigations into the roles of microtubules in 
lymphocyte motility
Introduction
All the three major cytoskeletal fibres - microfilaments, microtubules and intermediate 
filaments - and their associated proteins seem likely to contribute to the establishment of 
cell polarity and the process of cell translocation across surfaces. As discussed in the 
main introduction, the microfilament system is known to be intimately linked to the 
mechanism of movement and force generation^ The contributions of the microtubule 
and intermediate filament systems, however, are less clea/^^^\
Microtubules studies
As tools for investigating the importance of microtubules in lymphocyte motility, a 
number of microtubule - directed drugs were utilised in polarisation assays with fresh 
human PBTLs. Amongst the many microtubule - directed drugs, the taxol family are 
unusual in that they stabilise cytoskeletal microtubules against depolymerisation^^^^  ^ and 
induce polymerisation and bundling. It is now known that taxol inhibits the dynamic 
reactions at microtubule ends, suppressing both treadmilling and dynamic instability 
A representative experiment can be seen in figure 8.1, in which PBTLs were incubated 
with various concentrations of taxol for 30 minutes at 37°C and then stimulated with one 
of the 5 inducers of polarisation for 1 hour. All experimental results in this chapter were 
done in triplicate with 3 different blood donors. As can be seen from figure 8.1, taxol 
has significantly inhibited the extent of polarisation induced, even at concentrations as
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low as O.ljiM, This data suggests that microtubules must be remodelled, before shape 
change can take place.
Vinblastine binding to tubulin occurs rapidly and binding is rapidly reversible. Beginning 
with concentrations higher than approximately IpM, vinblastine depolymerises 
microtubules by causing splaying and peeling of protofilaments at both microtubule ends 
in Also unlike colchicine (described below), free vinblastine binds directly to
microtubule ends without first forming a complex with soluble tubulin^^^°\ Also 
vinblastine does not become incorporated into the tubulin lattice of the microtubule, but 
incorporates strictly at the microtubule ends^^^ \^ As can be seen in figure 8.2, fresh 
PBTLs incubated with various concentrations of vinblastine for 1 hour (at 37°C) exhibit 
rounding up of the cells at high concentrations and did not induce polarisation. Trypan 
blue tests showed that PBTLs incubated with lOOpM vinblastine were less than 10% 
non-viable (data not shown).
In figure 8.3, can be seen a representative experiment whereby PBTLs were incubated 
for 1 hour at 37°C in various concentrations of colchicine. As the concentration increases 
to lOOpM the extent of polarisation increases. In contrast with vinblastine, which binds 
directly to the ends of the microtubules, colchicine either cannot bind at all to 
microtubule ends or it does so very inefficiently. Instead, it first binds to soluble tubulin 
and forms a final-state tubulin-colchicine complex, which then incorporates at the 
microtubule ends through a polymerisation-dependent pathway
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Colchicine binding to tubulin is competitively inhibited by nocadazole^^^^  ^ and in figure 
8.4, can be seen a representative experiment in which PBTLs were incubated as above 
with various concentrations of nocadazole. the results here are similar to colchicine 
treated cells in that there is an increase in the polarisation of the cells up to 
approximately 35% at higher concentrations of the drug.
Vincristine differs from vinblastine only by the exchange of a methyl group for an 
aldehyde group, however, this has a major effect on the charge of the molecule and its 
effect on PBTL polarisation was different from vinblastine as shown in figure 8.5. 
Vincristine caused an increase in PBTLs polarisation of approx. 20% at low 
concentrations.
Colcemid (also known as demecolcine), is very similar to colchicine both structurally 
and functionally, in fact, colchicine only differs from colcemid by an extra carbon and 
oxygen. Colcemid, depolymerises microtubules and limits microtubule formation^ ^^ "^  ^ and 
it was also found to increase polarisation in PBTLS ("10%) (fig. 8.6) but not to the 
extent that was caused by nocadazole, colchicine or vincristine.
Thus, nocadazole, colchicine and colcemid have similar modes of action on 
microtubules, but vincristine is structurally very different from these molecules, however 
both types of molecules induce polarisation of PBTLs, indicating that these molecules do 
indeed target the microtubule system. Another piece of evidence to suggest that their 
effects on polarisation are via the microtubule system is the fact that taxol was found to 
neutralise the polarisation effects of nocadazole on PBTLs (see figure 8.1).
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Therefore, these data suggest that microtubules are playing an important role in the 
induction of polarisation of PBTLs, as when they are stabilised by taxol, polarisation 
cannot be induced, however when they are disrupted by various microtubule targetting 
drugs, the cells change shape, suggesting that microtubule disruption is a precursor to 
cell shape change.
In addition to observing the shape change effects of microtubule disrupting agents on 
PBTLs, the distribution of polymerised and depolymerised (3-tubulin in PBTLs before 
and after polarisation was investigated using immunofluoresence techniques (see 
methods). In figure 8.7, can be seen photographs of untreated fresh PBTLs stained for 
polymerised (3-tubulin. The polymerised P-tubulin is organised in spindle structures 
radiating from the microtubule organising centre. It must be noted at this point that all 
these pictures were taken at a 630x magnification, however the PBTLs are very small 
and not much detail can be attained in the immunofluoresence. Figure 8.8  shows PBTLs 
treated with lOpM Bis. and stained for polymerised P-tubulin. As can be seen in the 
polarised cells, the polymerised p-tubulin is located in spindles as before but is located 
behind the leading edge which is rich in filamentous actin (not shown). Thus, the 
polymerised p- tubulin seems to be confined to the main cell body and excluded from the 
cellular protrusions (see black arrows).
Depolymerised p-tubulin has a different cellular distribution from polymerised, as shown 
in figure 8.9, in which PBTLs (untreated) show a diffuse localisation of depolymerised 
P-tubulin with some capping of the distribution in some cells. PBTLs treated with lOpM 
Bis and stained for depolymerised p-tubulin (figure 8.10) exhibit a tubulin distribution
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which can only be described as more diffuse than in figure 8.8 but also more confined to 
the main cell body and excluded from the leading edge.
In summary, investigations into the roles of microtubules in lymphocyte motility, have 
shown that taxol blocks polarisation, therefore microtubule disassembly is essential for 
induction of polarisation in PBTLs. Also depolymerisation of microtubules by 
nocodazole, colchicine, colcemid and vincristine causes PBTL polarisation but not 
motility (as shown for nocodazole in chapter 3). Therefore, microtubule disassembly is 
required, but in itself is not sufficient for induction of motility.
Figure 8.1: The effect of taxol on the induction of polarisation in PBTLs
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Figure 8.2: The effect of vinblastine on the polarisation of PBTLs
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Figure 8.3: The effect of colchicine on the polarisation of PBTLs
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Figure 8.4: The effect of nocodazole on the polarisation of PBTLs
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Figure 8.5: The effect of vincristine on the polarisation of PBTLs
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Figure 8.6: The effect of colemîd on the polarisation of PBTLs
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Figure 8.7: Untreated PBTLs stained for polymerised B-tubulin (x630)
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Figure 8.8: PBTLs treated with lOuM Bis, stained for polymerised B-tubulin (x630)
i
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Figure 8.9: Untreated PBTLs stained for depolvmerised B-tubulin (x630)
#
@
O'
«te® %
125
Fig 8.10: PBTLs treated with lOuM Bis, stained for depolvmerised B-tubulin (x630)
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Chapter 9
Stnicture-activity relationship of inhihitors of 
lymphocyte motility.
During this project a number of compounds were found to have inhibitory effects on 
lymphocyte motility as measured by the polarisation assay. Most of these compounds are 
different from each other in their proposed targets (ie: herbimycin A is a tyrosine kinase 
inhibitor, whereas taxol is a microtubule stabiliser), however, they have all been found 
in this study to have one thing in common, which is the capability to inhibit, to varying 
degrees, the polarisation of PBTLs by shape change inducers. Therefore, it was decided 
to investigate whether there were any structural similarities between all these compounds 
which might be the reason for their common effects on PBTLs.
In figure 9.1 is shown the chemical structure of ionomycin which is a calcium ionophore 
and was found to significantly prevent the induction of shape change in PBTLs at a 
concentration of 10|iM as seen in fig. 4.9. Thapsigargin, the Ca^^-ATPase inhibitor was 
also found to inhibit PBTL polarisation at a concentration of lOpM (figure 4.12), and its 
chemical structure is depicted in figure 9.2. The structure of these compounds are very 
different and it seems unlikely that they have a common mechanism.
All the amiloride compounds (Na'"'/H'^ antiport blockers) which were tested in chapter 5 
for their ability to prevent PBTL polarisation are depicted in figure 9.3 (see chapter 5 
for full names). Their order of potency in inhibiting polarisation was
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A171 > A149> A130> A125> A113, which is consistent with their known effects on 
antiport blockade^^^^\ As can be seen from their chemical structures, they all 
have an aromatic core with amino groups in side chains.
In fîgure 9.4 can be seen the structures of the chloride channel blockers, NPPB, 
niflumic acid, quinidine and tamoxifen. From the data shown in chapter 5, the 
compounds NPPB and tamoxifen were the most potent polarisation inhibitors, however 
their structures are dissimilar and it may be that their effect on chloride channels are by 
different mechanisms (eg: direct blockade versus inhibition of a regulatory molecule).
The microtubule targetting drugs, taxol, vinblastine and vincristine are large polycyclic 
compounds and their structures are shown in figure 9.5. Taxol was found to be very 
effective at inhibiting polarisation in PBTLs (see fîgure 8.1) and vinblastine was found 
to round up freshly isolated PBTLs. Vincristine actually caused polarisation in PBTLs 
but its structure is shown here to show how similar vinblastine and vincristine are, as 
they differ only by a methyl group for an aldehyde group.
Wortmannin and LY294002 have been reported in the literature to be potent PI 3-kinase 
inhibitors and were shown in figures 4.14 and 4.15 to inhibit PBTL polarisation. 
However as mentioned in chapter 4, wortmannin inhibited polarisation at concentrations 
which are non-specific for PI 3-kinase. Their structures are shown in figure 9.6 and as 
you can see there is very little similarity between their structures.
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Herbimycin A, the tyrosine kinase inhibitor, was shown in figure 7.3 to inhibit a large 
percentage of PBTL polarisation and was later shown not to inhibit the tyrosine 
phosphorylation of pl20 by IL-2 and 11-15 (see chapter 7). It is a large cyclic compound 
as can be seen in figure 9.7 and has no similarity to any of the other compounds 
described in this chapter.
Trifluoperazine (TFP) is a compound which has been reported in the literature to inhibit 
motility in lymphocytes^^^^  ^ and is a member of the phenothiazine class of compounds 
which have been shown to have neuroleptic as well as immunosuppressive effects^ ^^ ^^  
possibly by disruption of the mechanisms regulating actin polym erisation^^The 
chemical structure of TFP is shown in figure 9.8 and its inhibitory effects on the 
induction of PBTL polarisation can be seen from the data in figure 9.9 This is a 
representative experiment from 3 experiments with 3 different blood donors. All tests 
were done in triplicate. In the experiments shown in fîgure 9.9, fresh PBTLs were 
incubated at 37°C with the relevant inducers of polarisation (eg: lL-2) for 40 minutes 
and then an appropriate concentration of TFP was added to the system and the PBTLs 
incubated for a further 20 minutes at 37°C, after which the cells were fixed and assessed 
for polarisation (see methods section). TFP was found to virtually abolish all polarisation 
at a 20nM concentration and trypan blue tests showed that less than 5 % of PBTLs were 
non-viable after a 20 minute exposure to 20pM TFP.
There does seem to be a superficial similarity between the structures of TFP (fîgure 9.8) 
and quinidine (figure 9.4), however their inhibitory effects on PBTL polmsation are not 
comparable as quinidine is virtually ineffective at 25pM (see figure 5.24) and only has
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a small effect at concentrations of lOOpM. The only other vague similarities that can be 
described are those between TFP and the amiloride compounds (Figure 9.3), in that they 
are all basic compounds with benzene rings, however TFP again proved to be much 
more potent than the amiloride compounds (figures 5.4 - 5.8).
In summary, it seems as though there is no strong structural motifs or similarities that 
are common to any of the compounds found to inhibit polarisation in PBTLs and 
therefore it must be assumed that they are all targetting separate systems within the cells.
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Figure 9.3: Amiloride compounds
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Figure 9.4: Chloride channel blockers
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Figure 9.5: Microtubule targetting drugs
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Figure 9.6: Phosphoinositide 3-kinase inhibitors
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Figure 9.7: Herbimvcin A
A
CHaO^ 
H3C...
O CH3
^OCHa
CH3O' CH3O T  T
ÔH3 CHa
Figure 9.8: Trifluoperazine
CH
CF
136
Figure 9.9: The effect of trifluoperazine on induction of polarisation in PBTLs
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10. Discussion
»
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In this project the aim was to investigate the second messengers involved in T- 
lymphocyte motility. The reason behind this being that, lymphocyte motility is an 
integral step in the multistep action of extravasation of T cells from blood vessels into 
sites of inflammation. Thus, if any information could be gained upon the signal 
transduction pathways used in the induction of motility, then these would be possible 
targets for pharmacological intervention, so as to prevent motility and the subsequent 
transmigration of the PBTLs through the endothelial walls into the surrounding tissue to 
cause an inflammatory reaction. Of course, this would also create problems in the 
normal recirculation of lymphocytes, so any potential anti-inflammatory compound 
which acts by inhibiting the induction of polarisation / motility, would be likely to be 
profoundly immunosuppressive.
The investigation for inducers of motilitv
A model of lymphocyte motility had to be established and various agonists were tested 
for their ability to cause polarisation (the first stage of motility) in fresh PBTLs and non 
motile MOLT-4 cells. Surprisingly, the much publicised chemokines had very little 
effect on the polarisation of freshly isolated PBTLs, with M IP-la, MIP-ip, MCP-1 and 
IL-8 only affecting a maximum of 10% of the population of cells. This could be due to 
the fact that each chemokine tends to be specific for a certain subset of T cells. The 
activation state of the lymphocytes also governs whether the cells respond to a certain 
factor, and this could also explain why factors such as substance P, VIP, LPA and 
PDGF, only had an effect on 10% of the PBTLs, as PBTLs are mostly unactivated in the 
peripheral blood.
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The MOLT-4 cells proved to be unresponsive to all of the factors tested except, Bis. and 
nocadazole. The reasons for this could be that either the MOLT-4 cells do not possess 
the receptors for any of these factors or it could be that pieces of the signal transduction 
machinery needed to relay the signals are missing or unable to function (which is a 
strong possibility, since these are transformed cells). For example, although the MOLT-4 
cell line is classified as a T cell lymphoblastic leukaemia it is actually negative for the 
CD3 marker^^^^\ Hence, it was decided to concentrate on using PBTLs as a model for 
induction of motility in lymphocytes as five factors were found to cause significant 
polarisation in PBTLs, these being. Bis - a PKC inhibitor, nocadazole- a microtubule 
disrupting agent, FCS - a mixture of unknown quantities of proteins and growth factors 
and finally the two interleukins-2 and -15, which are physiological agents involved in T 
cell regulation.
However, cell polarisation is only an indicator of motility as it does not always lead to 
cell locomotion. Therefore, these five factors were tested in transmigration assays and 
IL-2, IL-15 and Bis., were found to cause significant transmigration across 
polycarbonate filters, whereas FCS and nocadazole had no effect whatsoever. 
Nevertheless, FCS and nocadazole were still useful as tools for inducing polarisation in 
PBTLs as this is the crucial first step in motility - cells must change shape before they 
can become motile, therefore, nocadazole and FCS presumably use the same intracellular 
machinery as Bis. IL-2 and 11^15 to cause shape change
Rùle of intracellular calHum
Having established a model for the induction of motility in PBTLs, the next step was to 
investigate whether these 5 inducers of shape change utilised any common second
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messengers, that would then be contenders for involvement in a motility signal 
transduction pathway. It was found that none of the 5 factors caused any significant 
increases in [Ca^^]j that could be detected with the system used. Therefore, there could 
have been very small local fluctuations in [Ca^^]; within the cells that escaped detection. 
Also tested for effects on PBTLs levels, were some of the chemokines which
have been reported in the literature to cause transient [Ca^^]| increases. However, MIP- 
la , MIP-ip and MCP-1 had minimal effects on PBTLs in this system, with only an 
increase of about lOnM [Ca^ """]; being detected. This could be due to the fact that within 
each experiment there are 2x10^ PBTLs and only a subpopulation of these will respond 
to the chemokine in question, thus diluting the signal. Interleukin-8 and RANTES were 
found to have no effect whatsoever, but interestingly the non-motile MOLT -4 cells 
responded dramatically to MCP-1 and a few of the other P-chemokines with classical 
[Ca^^ji transients, proving that this system does indeed work, but more importantly 
showing that a physiological factor such as MCP-1 which causes a [Ca^^], transient 
increase does not affect the morphology of the cells.
Further investigations into [Ca^^]; and motility showed that an increase in [Ca^^j^ 
actually inhibits polarisation. First of all motile MOLT-4 cells and PBTLs that had 
previously been treated to cause polarisation were found to round up on exposure to 
ionomycin. At low concentrations (0.5pM), the calcium ionophore ionomycin 
preferentially inserts in the membrane of the intracellular stores^ ^^ ^^  and causes an 
increase in [Ca^^]; levels due to emptying of intracellular calcium stores. At higher 
concentrations (lOpM), the ionophore ionomycin, inserts into the cell membrane causing 
an influx of extracellular calcium into the cytosol. Thapsigargin treated PBTLs were 
unable to polarise upon exposure to the inducers of shape change due to the increase in
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[Ca ^]i levels elicited by the Ca^^-ATPase inhibitor. These results are supported by other 
workers^^°^’^ ®^\ who have also found that a [Ca^^], elevation in T-lymphocytes causes 
rounding up and immobilisation of the cells.
The [Ca^^]i dependence of lymphocyte motility is opposite to that described for other 
leukocytes where [Ca^^]. increases are associated with increased motility. For example, 
[Ca^^]i elevation speeds up neutrophil migration on various substrates^^^^\ via a 
calcineurin dependent mechanism^^^°\ Since stimuli (ionomycin and thapsigargin) that 
led to a rise also provoked a rounding of the lymphocyte, then there must be a
link between the cytoskeleton and calcium. Fragmentation of filamentous actin by 
calcium-dependent proteins (such as gelsolW^^^ )^ can explain some of these events. In 
neutrophils, a Ca^^-induced depolymerisation of actin has been shown^^^\ A correlation 
between [Ca^^ji augmentation and retraction of protrusions has been described in other 
cell types, for example cytotoxic T cells after interaction with a target cell^^^ \^ or 
endothelial cells stimulated with thrombin^^ '^^  ^ However, this is not necessarily true in all 
cell types. For instance, in neuroblastoma cells, although lysophosphatidic acid elicits 
both a [Ca^^ji rise and a neurite retraction, in this case the two events are not causally 
related^^^\
Local signalling events at the leading edge may be responsible for protrusion of a 
pseudopod by regulating actin-binding proteins. Although the studies with Ca -depleted 
cells show that changes in [Ca^^], are not a required part of the signal at the leading 
edge, localised brief increases in [Ca '^^Jj could play an auxiliary role in protrusion by 
generating additional actin-nucleation sites and by breaking crosslinks. With increased 
ability to measure [Ca^^], while observing morphological changes, and with improved
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methods to manipulate [Ca^^],, it should be possible to determine whether such local 
[Ca^^]i transients do play a functional role.
Role of phosphoinositides
The first set of experiments which investigated the role of phosphoinositides in 
lymphocyte motility were assays of IP3  levels within the cells. IP3  is an important second 
messenger as it can signal the endoplasmic reticulum to release its stores of Ca^^ and 
thus elevate the [Ca^^], levels. It was found that none of the five inducers of shape 
change had any effects on the IP3  levels after an arbitrary one minute period. The results 
from experiments whereby inhibitors of PI 3-kinase were used were unclear as 
w ortmannin was only inhibiting polarisation in PBTLs at concentrations at which is 
unspecific for PI 3-kinase. However, another PI 3-kinase inhibitor, LY294002 was 
found to significantly block the induction of motility in PBTLs at low concentrations. 
W ortmannin is known to be less stable than LY294002 and this could explain why it had 
less of an effect than LY294002, which then lead to the conclusion that PI 3-kinase could 
possibly be involved in the signal transduction of motility. Further evidence for the role 
of phosphoinositides in motility came from the experiments involving lithium chloride, 
which was found to inhibit the induction of shape change by IL-2, IL-15 and FCS (and 
Bis. and nocadazole, but at higher concentrations.). These results are not conclusive but 
they do suggest that phosphoinositides could be playing a role in motility signal 
transduction
Although no direct role for PI 3-kinasc in actin polymerisation has been demonstrated, it 
is neeessary for some forms of eell motility and adherence. PDGF receptor mutants that 
do not bind PI 3-kinase, do not ruffle or undergo chemotaxis in response to
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It has also been found that both PDGF receptor mutants that do not bind 
PI 3-kinase and wortmannin inhibit binding of GTP to rac in response to PDGF^^^\ 
These data place PI 3-kinase upstream of rac in fibroblasts and, consistent with this idea, 
injection of fibroblasts with V12 rac circumvents inhibition of ruffling by 
wortmannin^^^^\ Finally, although the biochemical mechanism is obscure, there is 
growing evidence both from receptor mutants and from inhibitors that PI 3-kinase is 
required for stimulus-dependent activation of integrins and cell adherence^^^®’^ ^^ ^
Role of intracellular pH and ion channels
Induction of shape change in PBTLs was found to have no effect on the intracellular pH 
of the cells as measured in this system. However, a decrease in pHj caused rounding up 
of motile MOLT-4 cells and blocked polarisation in PBTLs. One of the main pHj 
regulatory mechanisms is the Na'"'/H'*' antiporter and blockage of these was found to 
cause inhibition of motility in PBTLs and motile MOLTs.
Cytosolic pHj is a candidate to regulate cell motility, since certain steps in the actin 
polymerisation sequence and the binding of actin filaments to membrane-anchoring 
proteins are pH-dependent events^^^°\ Indirect observations are consistent with this 
notion: the ability of neutrophils to polarise and perform chemotaxis is reduced when the 
extracellular pH (pH^) is made more acidic, which is expected to lower pH/^^\ More 
importantly, it is possible to induce cytoskeletal reorganisation in neutrophils in a 
receptor-independent manner by the addition of weak electrolytes, which can modify pHj 
at constant pHg^^^\ Therefore, pH, must be given consideration as a regulator and 
possible mediator of cell shape change and chemotaxis.
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In a recent publication^^^^  ^ neutrophil spreading on adhesive substrates caused a rapid 
and sustained cytosolic alkalinisation. This pHj increase was prevented by the omission 
of external Na'*’, suggesting that it results from the activation of Na‘‘‘/H''’ exchange. It 
was also found that neutrophil motility was prevented by selectively blocking the NHE-1 
isoform of the Na'^'/H''' antiporter. Support for the results obtained in this project were 
also observed in that neutrophil spreading was strongly inhibited when pHj was clamped 
at acidic values^^^ \^ Interestingly, the inhibition of neutrophil shape change required pre­
acidification of the cells^ ^^ ^^  , since neutrophils spread normally when acidified shortly 
after contact with the substrate. This suggests that the pH-sensitive step is an early event, 
and that adherence and spreading, once initiated, can proceed independently of pH .^
It has been shown that there are interactions between actin filaments and the Na'*'/H'^ 
antiporte/^^^\ Also, microtubules have been suggested to have links with the Na’^ /H'*’ 
antiporter, which were shown to be regulated in a mechanosensitive manner in 
lymphocytes^^^^\ In addition, it has been shown in human B-lymphoid cells that the 
cAMP-mediated signal transduction pathway and pertussis toxin-sensitive GTP-binding 
proteins act synergistically to regulate amiloride-sensitive sodium channels^^ '^^^
Thus, it would seem that the the Na'*'/!!''’ antiporters play a vital role in lymphocyte 
motility, probably due to its role in pH, regulation which has effects on all enzymes 
within the cell and also it would seem through its interactions with the cytoskeleton.
Investigations into the roles of chloride channels in lymphocyte motility showed that 
various chloride channel blockers could inhibit PBTLs and motile MOLTs polarisation 
effectively, however it was found that the blockers were not actually exerting their
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motility inhibitory effects via chloride channel blockage but through other mechanisms 
which are unknown. Therefore, the role of chloride channels in lymphocyte motility 
remains unclear at this point, however it can be assumed that they would play at least 
some minor role in the complicated entanglement that is the signal transduction 
regulation of motility, as chloride channels are important in cell volume 
control^°^'^°^'^^\ as well as pH; control via the CI /HCO3 antiport exchanger^°^'^^\ A 
CI /HCO3 antiport exchanger, similar to the band 3 protein in the membrane of red 
blood cells, is thought to play an important part in pH; regulation in many nucleated 
cells. Like the Na'"'/H'^ exchanger, the CI /HCO3 antiport exchanger is regulated by pH;, 
but in the opposite direction. Its activity increases as pH; rises, increasing the rate at 
which HCO3 is ejected from the cell in exchange for Cl’, thereby decreasing pH; 
whenever the cytosol becomes too alkaline. Also, it must be noted at this point that the 
importance of chloride channels in motility may not be just due to their physiological 
role in Cl' transport but to their permeability to larger organic osmolytes such as
The role of renaturahle kinases
Investigations into the role of renaturahle kinases in PBTL motility, showed that of the 
five inducers of motility, only Bis. seemed to have any effects, in that it repeatedly 
activated a renaturahle autophosphorylating kinase of molecular weight 58kDa. 
Collaborative work in the same laboratory has identified this 58kDa kinase to be MST-1 
(mammalian Ste20-like), a serine/threonine protein kinase. Little is known about this 
kinase at the current time, however its role in the signal transduetion of motility in 
PBTLs cannot be considered too important as the other four inducers of motility failed to 
activate it in this assay.
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The role of tvrosine phosphorylation
In this study it was found that of the five inducers of polarisation in PBTLs only IL-2 
and IL-15 caused tyrosine phosphorylation of proteins that were detected in this system. 
Both IL-2 and IL-15 were found to cause tyrosine phosphorylation of a protein of 
molecular weight approximately llOkDa (pi 10). Of the tyrosine kinase inhibitors used, 
only herbimycin A was found to block polarisation of PBTLs and more importantly it 
was capable of inhibiting shape change in PBTLs by all five of the inducers of motility 
effectively. This suggested that herbimycin A was targeting a point in the signal 
transduction system that was utilised by all five factors. Similar results have been 
obtained with neutrophils pre-treated with herbimycin A, in that it blocks their 
chemotactic response to fMLP^^^ .^ It should be noted at this point however, that 
herbimycin A is not necessarily blocking shape change by inhibition of a tyrosine kinase, 
it could be due to other adverse effects. Further evidence to suppport this notion was 
obtained in the experiments in whieh it was found that PBTLs pre-treated with 
herbimycin A before exposure to IL-2 or IL-15 were still found to cause tyrosine 
phosphorylation of pi 10. Thus, if herbimycin A is indeed inhibiting polarisation by 
targeting a tyrosine kinase then it must be downstream from the pi 10 protein. 
Identification of the p i 10 protein has been unsuccessful. Evidence from the literature 
would suggest the most likely candidate to be Janus kinase-3 (JAK-3), as this protein has 
been shown to be tyrosine phosphorylated by both IL-2 and IL-15 in T cells^ ^^ ^^  and has a 
molecular weight of approximately 120kDa. However, experiments to immunoprecipitate 
the p i 10 protein using anti-JAK-3 antibodies proved unsuccessful. Therefore, it is 
uncertain at this point whether the p i 10 protein is indeed JAK-3, however, whatever the
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identity of the protein it is possible that it is part of a motility signal transduction 
pathway utilised by IL-2 and IL-15.
Indeed, it has been shown in neutrophils treated with chemotactic agents such as fMLP, 
that they also cause tyrosine phosphorylation of a protein of molecular weight 
120kDa^ ^^ ^^  - (identity unknown at time of publication).
Role of microtubules
To evaluate the involvement of microtubules in PBTL polarisation, a number of 
microtubule targeting drugs were used on the PBTLs. From these results it was clear that 
before the PBTLs could change shape, the microtubular system must be rearranged. This 
was deduced from experiments with taxol. The effect of taxol at the molecular level is 
opposite to that of the other microtubule targeting drugs used, such as colchicine. Taxol 
stabilises microtubules in a polymerised state^^^\ Due to this effect, taxol promotes 
polymerisation of free microtubules not associated with any organising centers, so that 
gradually the system of microtubules radiating from the perinuclear center is replaced by 
numerous aggregates of free microtubules^^^^\ This disintegration of the microtubule 
system was found to be accompanied by the inabilty of the PBTLs to polarise in réponse 
to the five inducers of shape change. Also, it was found that agents such as colchicine 
and nocadazole which disrupt microtubules, could cause shape change in PBTLs 
themselves.
Immunofluorescence photographs of unactivated PBTLs stained for polymerised and 
depolymerised P-tubulin show that they have different cellular distribution profiles but in 
polarised PBTLs both types of tubulin seemed to be excluded from the leading edge of
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the cell which is rich in F-actin microfilaments forming a cortical meshwork. Indeed, it 
has been found that polarised motile fibroblasts are characterised by trailing processes 
rich in microtubules^^^*^
What then is the role of microtubules in PBTLs motility? Unfortunately, there is little 
published work on this subject concerning PBTLs, however there are theories on the 
subject. One hypothesis, originally proposed in is that the microtubules
transport new membrane and cortical components from the golgi apparatus to the leading 
edge. One reason that the microtubules need to be disrupted prior to polarisation is a 
structural one, in that the intracellular scaffolding has to be re-arranged before the cell 
can change shape. Also, it could be that the disruption of the microtubule network allows 
the release of second messengers that are bound to the microtubules, so that they are then 
free to take part in signal transduction.
Therefore, it would seem that PBTL polarisation is stabilised first by reorganisation of 
the actin cortex induced by the extension of pseudopods; in the next stage polarisation is 
enhanced and further stabilised by the microtubule-dependent redistribution of organelles
Inhibitors of lymphocyte polarisation
After assessing the chemical structures of all the compounds which inhibited PBTL 
polarisation, it was found that there were no significant structural similarities between 
any of the compounds that may explain their common effects on PBTLs polarisation. 
Therefore, it must be assumed that they are all targeting separate systems within the 
cells.
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Conclusion
Thus, five different factors were found to cause significant polarisation in PBTLs, but no 
common second messenger elements were found to be utilised by the five. However, a 
number of pharmacological agents were found, that prevented induction of polarisation in 
PBTLs by all five factors and these it would seem may be targeting unknown second 
messenger elements involved in the signal transduction of T-lymphocyte motility, or the 
intracellular motility machinery itself.
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